,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,1,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line,Confirmatory,,
1,3,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line,Confirmatory,,
2,5,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line,Confirmatory,,
3,7,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line,Confirmatory,,
4,9,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line,Confirmatory,,
5,13,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line,Confirmatory,,
6,15,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line,Confirmatory,,
7,19,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line,Confirmatory,,
8,21,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line,Confirmatory,,
9,23,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line,Confirmatory,,
10,25,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line,Confirmatory,,
11,31,1,1,,570242,14710,Unspecified,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line,Confirmatory,,
12,33,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line,Confirmatory,,
13,35,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line,Confirmatory,,
14,37,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line,Confirmatory,,
15,39,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line,Confirmatory,,
16,41,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the PC-3 Prostate cell line,Confirmatory,,
17,43,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line,Confirmatory,,
18,45,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line,Confirmatory,,
19,47,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line,Confirmatory,,
20,49,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line,Confirmatory,,
21,53,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line,Confirmatory,,
22,55,1,1,,570242,14710,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line,Confirmatory,,
23,59,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line,Confirmatory,,
24,65,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line,Confirmatory,,
25,67,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line,Confirmatory,,
26,71,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line,Confirmatory,,
27,73,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line,Confirmatory,,
28,77,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line,Confirmatory,,
29,79,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line,Confirmatory,,
30,81,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line,Confirmatory,,
31,83,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line,Confirmatory,,
32,85,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-435 Breast cell line,Confirmatory,,
33,87,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line,Confirmatory,,
34,89,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the BT-549 Breast cell line,Confirmatory,,
35,91,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the T-47D Breast cell line,Confirmatory,,
36,93,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI/ADR-RES Breast cell line,Confirmatory,,
37,95,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-231/ATCC Breast cell line,Confirmatory,,
38,97,1,1,,570242,14710,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HS 578T Breast cell line,Confirmatory,,
39,99,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line,Confirmatory,,
40,101,1,1,,570242,14710,Unspecified,,,,,NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line,Confirmatory,,
41,103,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line,Confirmatory,,
42,105,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line,Confirmatory,,
43,107,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line,Confirmatory,,
44,109,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line,Confirmatory,,
45,113,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line,Confirmatory,,
46,115,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line,Confirmatory,,
47,119,1,1,,570242,14710,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line,Confirmatory,,
48,121,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line,Confirmatory,,
49,123,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line,Confirmatory,,
50,125,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line,Confirmatory,,
51,129,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line,Confirmatory,,
52,131,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line,Confirmatory,,
53,133,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line,Confirmatory,,
54,137,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line,Confirmatory,,
55,139,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line,Confirmatory,,
56,141,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line,Confirmatory,,
57,143,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line,Confirmatory,,
58,145,1,1,,570242,14710,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line,Confirmatory,,
59,155,1,1,,570242,14710,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
60,157,1,1,,570242,14710,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
61,161,1,1,,570242,14710,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
62,165,1,1,,570242,14710,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
63,167,1,1,,570242,14710,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
64,175,1,1,,570242,14710,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
65,179,1,1,,570242,14710,Inactive,,,,,NCI AIDS Antiviral Assay,Confirmatory,,
66,328,1,1,,570242,14710,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
67,330,1,1,,570242,14710,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
68,421,1,3,,17389015,14710,Inconclusive,,,,,Cell Viability - BJ,Confirmatory,,
69,426,1,2,,17389015,14710,Active,,,,,Cell Viability - Jurkat,Confirmatory,,
70,427,1,1,,17389015,14710,Inconclusive,,,,,Cell Viability - Hek293,Confirmatory,,
71,433,1,1,,17389015,14710,Inactive,,,,,Cell Viability - HepG2,Confirmatory,,
72,434,1,2,,17389015,14710,Inactive,,,,,Cell Viability - MRC5,Confirmatory,,
73,435,1,2,,17389015,14710,Inactive,,,,,Cell Viability - SK-N-SH,Confirmatory,,
74,445,3,1,,17389015,14710,Inconclusive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
75,530,1,1,,17389015,14710,Inconclusive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
76,540,1,1,,17389015,14710,Active,,,,,Cell Viability - N2a,Confirmatory,,
77,541,1,1,,17389015,14710,Inconclusive,,,,,Cell Viability - NIH 3T3,Confirmatory,,
78,542,1,1,,17389015,14710,Inconclusive,,,,,Cell Viability - HUV-EC-C,Confirmatory,,
79,543,1,1,,17389015,14710,Inconclusive,,,,,Cell Viability - H-4-II-E,Confirmatory,,
80,544,2,1,,17389015,14710,Inconclusive,,,,,Cell Viability - SH-SY5Y,Confirmatory,,
81,545,1,1,,17389015,14710,Inconclusive,,,,,Cell Viability - Renal Proximal Tubule,Confirmatory,,
82,546,1,1,,17389015,14710,Active,,,,,Cell Viability - Mesenchymal,Confirmatory,,
83,584,1,3,,17389015,14710,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
84,585,1,4,,17389015,14710,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
85,595,1,3,,17389015,14710,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
86,596,1,2,,17389015,14710,Active,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
87,603,1,2,,17389015,14710,Active,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
88,605,1,2,,17389015,14710,Active,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
89,654,1,1,,17389015,14710,Inactive,,,,,Cellular Toxicity (caspase-3) HepG2,Confirmatory,,
90,655,1,1,,17389015,14710,Inactive,,,,,Cellular Toxicity (caspase-3) Jurkat,Confirmatory,,
91,656,1,1,,17389015,14710,Inactive,,,,,Cellular Toxicity (caspase-3) HUV-EC-C,Confirmatory,,
92,657,1,1,,17389015,14710,Inactive,,,,,Cellular Toxicity (caspase-3) SHSY5Y,Confirmatory,,
93,658,1,1,,17389015,14710,Inactive,,,,,Cellular Toxicity (caspase-3) BJ,Confirmatory,,
94,659,1,1,,17389015,14710,Inactive,,,,,Cellular Toxicity (caspase-3) MRC-5,Confirmatory,,
95,660,1,1,,17389015,14710,Inactive,,,,,Cellular Toxicity (caspase-3) Mesangial,Confirmatory,,
96,661,1,1,,17389015,14710,Inactive,,,,,Cellular Toxicity (caspase-3) SK-N-SH,Confirmatory,,
97,662,1,1,,17389015,14710,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
98,663,1,1,,17389015,14710,Inactive,,,,,Cellular Toxicity (caspase-3) H-4-II-E,Confirmatory,,
99,664,1,1,,17389015,14710,Inactive,,,,,Cellular Toxicity (caspase-3) Hek293,Confirmatory,,
100,665,1,1,,17389015,14710,Inactive,,,,,Cellular Toxicity (caspase-3) N2a,Confirmatory,,
101,666,1,1,,17389015,14710,Inconclusive,,,,,Cellular Toxicity (caspase-3) NIH 3T3,Confirmatory,,
102,667,1,1,,17389015,14710,Inactive,,,,,Cellular Toxicity (caspase-3) Renal Proximal Tubule,Confirmatory,,
103,875,1,2,,17389015,14710,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
104,875,1,2,,26748838,14710,Inconclusive,159162802.0,,12.5893,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
105,880,2,1,,17389015,14710,Active,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
106,880,2,1,,17389015,14710,Active,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
107,880,2,1,,26748838,14710,Active,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
108,880,2,1,,26748838,14710,Active,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
109,881,2,2,,17389015,14710,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
110,881,2,2,,26748838,14710,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
111,884,1,2,,17389015,14710,Active,13435386.0,1576.0,10.0,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
112,884,1,2,,26748838,14710,Inconclusive,13435386.0,1576.0,6.3096,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
113,885,1,2,,17389015,14710,Inactive,13435386.0,1576.0,10.0,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
114,885,1,2,,26748838,14710,Inactive,13435386.0,1576.0,6.3096,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
115,886,1,2,,17389015,14710,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
116,886,1,2,,17389015,14710,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
117,887,1,2,,17389015,14710,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
118,887,1,2,,26748838,14710,Active,1832253.0,246.0,10.0,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
119,889,1,3,,17389015,14710,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
120,889,1,3,,26748838,14710,Inconclusive,1730092.0,840.0,6.3096,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
121,892,1,2,,17389015,14710,Inconclusive,159162802.0,,39.8107,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
122,892,1,2,,26748838,14710,Inconclusive,159162802.0,,19.9526,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
123,893,1,2,,17389015,14710,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
124,893,1,2,,17389015,14710,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
125,893,1,2,,26748838,14710,Active,122921310.0,,19.9526,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
126,893,1,2,,26748838,14710,Active,122921311.0,,19.9526,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
127,894,2,1,,17389015,14710,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
128,894,2,1,,26748838,14710,Active,31542939.0,3248.0,35.4813,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
129,900,1,3,,17389015,14710,Inconclusive,15431328.0,834.0,5.0119,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
130,900,1,3,,26748838,14710,Inconclusive,15431328.0,834.0,7.9433,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
131,902,1,2,,17389015,14710,Inconclusive,120407068.0,7157.0,2.5119,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
132,902,1,2,,26748838,14710,Active,120407068.0,7157.0,2.5119,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
133,910,1,2,,26748838,14710,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus,Confirmatory,,
134,912,1,2,,17389015,14710,Inconclusive,21392848.0,,2.5119,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
135,921,1,2,,17389015,14710,Active,,,7.9433,Potency,Cell Viability - LYMP2-001,Confirmatory,,
136,923,1,2,,17389015,14710,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
137,923,1,2,,26748838,14710,Inconclusive,,,7.9433,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
138,924,1,2,,17389015,14710,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
139,924,1,2,,26748838,14710,Active,120407068.0,7157.0,3.9811,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
140,925,1,2,,17389015,14710,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
141,926,1,2,,17389015,14710,Inconclusive,38016895.0,7253.0,31.6228,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
142,927,1,3,,26748838,14710,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
143,930,1,2,,26748838,14710,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus,Confirmatory,,
144,938,1,2,,17389015,14710,Inconclusive,38016895.0,7253.0,31.6228,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
145,940,1,2,,26612529,14710,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
146,946,1,2,,17389015,14710,Active,,,39.8107,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells,Confirmatory,,
147,947,1,2,,17389015,14710,Active,,,25.1189,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells,Confirmatory,,
148,948,1,2,,17389015,14710,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP1-002 - Assay at 16 hr,Confirmatory,,
149,955,1,2,,17389015,14710,Inconclusive,,,12.5893,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells,Confirmatory,,
150,960,1,2,,17389015,14710,Inconclusive,,,31.6228,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells,Confirmatory,,
151,961,1,2,,17389015,14710,Active,,,39.8107,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells,Confirmatory,,
152,962,1,2,,17389015,14710,Active,,,12.5893,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells,Confirmatory,,
153,963,1,2,,17389015,14710,Active,,,15.8489,Potency,Cell Viability - LYMP1-003 - Assay at 24 hr,Confirmatory,,
154,964,1,2,,17389015,14710,Active,,,6.3096,Potency,Cell Viability - LYMP1-003 - Assay at 40 hr,Confirmatory,,
155,965,1,2,,17389015,14710,Active,,,31.6228,Potency,Cell Viability - LYMP2-003,Confirmatory,,
156,966,1,2,,17389015,14710,Inconclusive,,,31.6228,Potency,Cell Viability - LYMP2-004,Confirmatory,,
157,967,1,2,,17389015,14710,Active,,,6.3096,Potency,Cell Viability - LYMP2-005,Confirmatory,,
158,968,1,2,,17389015,14710,Active,,,15.8489,Potency,Cell Viability - LYMP2-009,Confirmatory,,
159,969,1,2,,17389015,14710,Active,,,12.5893,Potency,Cell Viability - LYMP2-011,Confirmatory,,
160,970,1,2,,17389015,14710,Active,,,15.8489,Potency,Cell Viability - LYMP2-013,Confirmatory,,
161,971,1,2,,17389015,14710,Active,,,15.8489,Potency,Cell Viability - LYMP2-015,Confirmatory,,
162,972,1,2,,17389015,14710,Active,,,15.8489,Potency,Cell Viability - LYMP2-017,Confirmatory,,
163,973,1,2,,17389015,14710,Active,,,12.5893,Potency,Cell Viability - LYMP2-019,Confirmatory,,
164,974,1,2,,17389015,14710,Active,,,19.9526,Potency,Cell Viability - LYMP2-021,Confirmatory,,
165,975,1,2,,17389015,14710,Active,,,15.8489,Potency,Cell Viability - LYMP2-023,Confirmatory,,
166,976,1,2,,17389015,14710,Active,,,15.8489,Potency,Cell Viability - LYMP2-025,Confirmatory,,
167,977,1,2,,17389015,14710,Active,,,15.8489,Potency,Cell Viability - LYMP2-002,Confirmatory,,
168,978,1,2,,17389015,14710,Active,,,10.0,Potency,Cell Viability - LYMP2-006,Confirmatory,,
169,979,1,2,,17389015,14710,Active,,,12.5893,Potency,Cell Viability - LYMP2-007,Confirmatory,,
170,980,1,2,,17389015,14710,Active,,,10.0,Potency,Cell Viability - LYMP2-008,Confirmatory,,
171,981,1,2,,17389015,14710,Active,,,12.5893,Potency,Cell Viability - LYMP2-010,Confirmatory,,
172,982,1,2,,17389015,14710,Active,,,7.9433,Potency,Cell Viability - LYMP2-012,Confirmatory,,
173,983,1,2,,17389015,14710,Active,,,10.0,Potency,Cell Viability - LYMP2-014,Confirmatory,,
174,984,1,2,,17389015,14710,Active,,,15.8489,Potency,Cell Viability - LYMP2-016,Confirmatory,,
175,985,1,2,,17389015,14710,Active,,,10.0,Potency,Cell Viability - LYMP2-018,Confirmatory,,
176,986,1,2,,17389015,14710,Active,,,15.8489,Potency,Cell Viability - LYMP2-020,Confirmatory,,
177,987,1,2,,17389015,14710,Active,,,7.9433,Potency,Cell Viability - LYMP2-022,Confirmatory,,
178,988,1,2,,17389015,14710,Active,,,12.5893,Potency,Cell Viability - LYMP2-024,Confirmatory,,
179,989,1,2,,17389015,14710,Active,,,15.8489,Potency,Cell Viability - LYMP2-026,Confirmatory,,
180,993,1,2,,17389015,14710,Active,,,31.6228,Potency,Cell Viability - LYMP1-002 - Assay at 24 hr,Confirmatory,,
181,994,1,2,,17389015,14710,Active,,,31.6228,Potency,Cell Viability - LYMP1-002 - Assay at 40 hr,Confirmatory,,
182,995,1,2,,17389015,14710,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
183,995,1,2,,26748838,14710,Inconclusive,66932916.0,5594.0,25.1189,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
184,1030,2,1,,17389015,14710,Inconclusive,30582681.0,216.0,39.8107,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
185,1030,2,1,,26748838,14710,Inactive,30582681.0,216.0,0.0597,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
186,1379,1,2,,26748838,14710,Inconclusive,1669525.0,,15.8489,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
187,1422,1,1,,26612529,14710,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
188,1452,1,1,,17389015,14710,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
189,1452,1,1,,26748838,14710,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
190,1454,1,1,,26748838,14710,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
191,1457,1,1,,17389015,14710,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
192,1457,1,1,,26748838,14710,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
193,1458,1,1,,17389015,14710,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
194,1458,1,1,,26748838,14710,Inactive,10937869.0,6607.0,10.0,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
195,1460,1,3,,26748838,14710,Active,92096784.0,4137.0,4.4668,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
196,1463,1,1,,26748838,14710,Inconclusive,,,1.4125,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
197,1467,1,3,,26748838,14710,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
198,1468,1,1,,26748838,14710,Active,92096784.0,4137.0,8.9125,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
199,1469,1,1,,17389015,14710,Active,189491771.0,7068.0,35.4813,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
200,1469,1,1,,26748838,14710,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
201,1471,2,1,,17389015,14710,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
202,1471,2,1,,26748838,14710,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
203,1476,2,1,,17389015,14710,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
204,1476,2,1,,26748838,14710,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
205,1478,2,1,,17389015,14710,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
206,1478,2,1,,26748838,14710,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
207,1479,1,2,,17389015,14710,Active,189491771.0,7068.0,44.6684,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
208,1479,1,2,,26748838,14710,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
209,1487,1,1,,26748838,14710,Inconclusive,27436948.0,4000.0,22.3872,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
210,1490,2,1,,17389015,14710,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
211,1490,2,1,,26748838,14710,Inconclusive,10954339.0,,44.6684,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
212,1519,1,3,,26748838,14710,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
213,1580,1,1,,8150046,14710,Inconclusive,,,,,Screen for compounds that inhibit mitochondrial permeability transition (MitoPT),Other,,
214,1581,1,1,,8150046,14710,Inconclusive,,,,,Screen of Compounds to Block PAR4 - aPKC Interaction for Treatment of Neurodegeneration (Par4_PKC),Other,,
215,1582,1,1,,8150046,14710,Inconclusive,,,,,Yeast cell-based screen for Novel HDAC inhibitors using a PHO84-LacZ reporter gene (PHO84),Other,,
216,1583,1,1,,8150046,14710,Unspecified,,,,,Assay to identify inhibitors of polyglutamine-induced caspase-3 activation (CASP3),Other,,
217,1584,1,1,,8150046,14710,Inconclusive,,,,,Screen for compounds that inhibit in vitro mutant huntingtin aggregation (QA1),Other,,
218,1585,1,1,,8150046,14710,Inconclusive,,,,,"Screen for compounds that inhibit the ability of solid phase synthetic polyglutamine aggregates to elongate by incorporating solution-phase biotin-tagged, monomeric polyglutamine (QA3)",Other,,
219,1586,1,1,,8150046,14710,Inconclusive,,,,,A 2-Hybrid Test for Interactions Between Polyglutamine-Containing Proteins in the Yeast Nucleus  (Qn2Hy),Other,,
220,1587,1,1,,8150046,14710,Inconclusive,,,,,Screen for compounds that increase the expression of EAAT-2 in rat spinal cord organotypic slice cultures (X4_EAAT2),Other,,
221,1588,1,1,,8150046,14710,Inconclusive,,,,,Screen for compounds that reduce polyglutamine aggregation as measured by turbidity (QTHIO),Other,,
222,1589,1,1,,8150046,14710,Inconclusive,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (SDS),Other,,
223,1590,1,1,,8150046,14710,Inconclusive,,,,,Cellular toxicity caused by inducible expressing of N-terminal huntingtin with expanded ployglutamine repeat (Htt-N63-148Q) in PC12 cells (ROSShtt),Other,,
224,1593,1,1,,8150046,14710,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubU),Other,,
225,1594,1,1,,8150046,14710,Inconclusive,,,,,Screen for compounds that decrease glutamate induced motor neuron death measured by TUNEL staining for DNA degradation (MNGlu),Other,,
226,1595,1,1,,8150046,14710,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYe),Other,,
227,1596,1,1,,8150046,14710,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH100),Other,,
228,1597,1,1,,8150046,14710,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYp),Other,,
229,1598,1,1,,8150046,14710,Inconclusive,,,,,Screen for compounds that selectively increase SMN2 splicing relative to SMN1 splicing (SMNLUC),Other,,
230,1599,1,1,,8150046,14710,Unspecified,,,,,"Screen for compounds that correct neuronal dysfunction without cell death as induced by the expression of polyglutamine-expanded, N-terminal huntingtin in C. elegans mechanosensory neurons (HDELENEU)",Other,,
231,1600,1,1,,8150046,14710,Inconclusive,,,,,Yeast Assay for Parkinson&apos;s Disease (YAPD),Other,,
232,1601,1,1,,8150046,14710,Inconclusive,,,,,Screen for compounds that suppress mutant SOD1-mediated cell death (mSODtox),Other,,
233,1602,1,1,,8150046,14710,Inconclusive,,,,,Screen for compounds that attenuate mutant SOD1 toxicity (mSOD1),Other,,
234,1603,1,1,,8150046,14710,Unspecified,,,,,Screen for compounds that selectively inhibit cytochrome c release from purified mitochondria (CytoCRel),Other,,
235,1604,1,1,,8150046,14710,Unspecified,,,,,Screen for compounds that inhibit polyglutamine induced protein aggregation (AGREG),Other,,
236,1605,1,1,,8150046,14710,Unspecified,,,,,Screening of compounds showing protective effect against cell death induced by familial amyotrophic lateral sclerosis (FALS)-linked mutantsuperoxide dismutase 1 (SOD1) (ALSOD1),Other,,
237,1606,1,1,,8150046,14710,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH20),Other,,
238,1607,1,1,,8150046,14710,Inconclusive,,,,,Screen for compounds that promote the turnover of an expanded polyglutamine androgen receptor (AR112GFP),Other,,
239,1608,1,1,,8150046,14710,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH016),Other,,
240,1609,1,1,,8150046,14710,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH08),Other,,
241,1610,1,1,,8150046,14710,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells,Other,,
242,1612,1,1,,8150046,14710,Unspecified,,,,,Screen for compounds that increase glutamate transport activity in MN-1 cell line (GluUPTAKE),Other,,
243,1613,1,1,,8150046,14710,Unspecified,,,,,Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1),Other,,
244,1614,1,1,,8150046,14710,Unspecified,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (GFPQ80),Other,,
245,1616,1,1,,8150046,14710,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubH),Other,,
246,1688,1,1,,17389015,14710,Active,90903231.0,3064.0,14.1254,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
247,1688,1,1,,26748838,14710,Inconclusive,90903231.0,3064.0,22.3872,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
248,1865,1,1,,26748838,14710,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
249,1948,1,1,,17389015,14710,Inactive,,,5.0119,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
250,1948,1,1,,26748838,14710,Inactive,,,31.6228,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
251,2098,1,1,,92764758,14710,Inactive,62740231.0,15499.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1).,Screening,,
252,2101,1,1,,17389015,14710,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
253,2101,1,1,,26748838,14710,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
254,2107,1,1,,17389015,14710,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
255,2107,1,1,,26748838,14710,Inconclusive,757912.0,2717.0,35.4813,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
256,2112,1,1,,17389015,14710,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
257,2112,1,1,,26748838,14710,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
258,2120,1,1,,17389015,14710,Inconclusive,32879895.0,3091.0,39.8107,Potency,qHTS Assay for Identification of Small Molecule Inducers of Hypoxia Response,Confirmatory,,
259,2147,1,1,,26748838,14710,Inconclusive,221046486.0,,1.0,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
260,2451,1,2,,26748838,14710,Inconclusive,122920737.0,,1.2589,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
261,2472,1,2,,26748838,14710,Active,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
262,2517,2,1,,17389015,14710,Active,6980812.0,,31.6228,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
263,2517,2,1,,144204963,14710,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
264,2528,1,2,,17389015,14710,Inconclusive,4557365.0,641.0,39.8107,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
265,2528,1,2,,26748838,14710,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
266,2546,1,1,,17389015,14710,Active,188536040.0,19885.0,11.2202,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
267,2546,1,1,,26748838,14710,Inconclusive,188536040.0,19885.0,11.2202,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
268,2549,1,1,,17389015,14710,Active,282403581.0,,35.4813,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
269,2549,1,1,,26748838,14710,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
270,2551,1,1,,17389015,14710,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
271,2551,1,1,,26748838,14710,Inconclusive,188536040.0,19885.0,35.4813,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
272,2662,2,1,,17389015,14710,Inconclusive,56550039.0,4297.0,35.4813,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
273,2662,2,1,,26748838,14710,Inconclusive,56550039.0,4297.0,44.6684,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
274,2778,1,2,,17389015,14710,Inconclusive,18860839.0,4221.0,794.328,Potency,Confirmation of Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Confirmation in an HTRF (commercial TR-FRET) Assay using His-tagged menin and biotin-labeled MLL peptide,Confirmatory,,
275,2778,1,2,,17389015,14710,Inconclusive,56550039.0,4297.0,794.328,Potency,Confirmation of Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Confirmation in an HTRF (commercial TR-FRET) Assay using His-tagged menin and biotin-labeled MLL peptide,Confirmatory,,
276,2782,1,2,,17389015,14710,Inconclusive,18860839.0,4221.0,70.9627,Potency,Confirmation of Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
277,2782,1,2,,17389015,14710,Inconclusive,56550039.0,4297.0,70.9627,Potency,Confirmation of Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
278,2783,1,2,,17389015,14710,Inconclusive,18860839.0,4221.0,22.3872,Potency,Confirmation of Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
279,2783,1,2,,17389015,14710,Inconclusive,56550039.0,4297.0,22.3872,Potency,Confirmation of Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
280,23271,4,4,,103207558,14710,Unspecified,,,,,Partition coefficient (logD7.4),Other,2362268.0,
281,26756,3,4,,103207558,14710,Unspecified,,,,,DNA binding dissociation constant as KD,Other,6708048.0,
282,31892,3,3,,103207558,14710,Unspecified,,,,,Thermal denaturation in alternating poly(dA-dT)poly(dA-dT) homopolymer (AT),Other,8510102.0,
283,31893,3,3,,103207558,14710,Unspecified,,,,,Thermal denaturation in sonicated poly(dA)-poly(dT) homopolymer (AT),Other,8510102.0,
284,45400,3,4,,103207558,14710,Unspecified,,,,,Effect on cross resistance of CHO cells resistant to colchicine (CHRC5),Other,2362268.0,
285,46158,4,1,,103207558,14710,Unspecified,,,,,Binding constant(K) for calf thymus DNA in 50 mM Tris-HCl buffer at pH 7.5 0.015 M NaCl,Other,,
286,53470,5,1,,103207558,14710,Unspecified,300669716.0,,,,Inhibitory dose against oncornaviral DNA polymerase activity of moloney murine leukemia virus,Other,6157024.0,
287,54423,4,1,,103207558,14710,Unspecified,,,,,Denaturation temperature change on binding to AT to poly (dA)-poly(dT),Other,1738139.0,
288,54424,4,1,,103207558,14710,Unspecified,,,,,Denaturation temperature change on binding on GC to poly(dGC)-poly(dGC),Other,1738139.0,
289,54425,4,1,,103207558,14710,Unspecified,,,,,"DNA binding property estimated by measuring denaturation temperature on GC to poly (dGC)-poly(dGC), normalized to ethidium bromide",Other,1738139.0,
290,54426,4,1,,103207558,14710,Unspecified,,,,,Denaturation temperature change on binding to calf thymus DNA,Other,1738139.0,
291,54427,4,1,,103207558,14710,Unspecified,,,,,DNA binding activity as denaturation temperatures on AT to poly (dA)-poly(dT) normalized to ethidium bromide,Other,1738139.0,
292,54452,5,1,,103207558,14710,Unspecified,,,,,Activity against DNA binding in calf thymus was determined,Other,2441055.0,
293,54646,4,2,,103207558,14710,Unspecified,,,,,Intrinsic association constant for DNA,Other,15026041.0,
294,54984,3,3,,103207558,14710,Unspecified,,,,,Thermal denaturation in sonicated calf thymus DNA (CT DNA),Other,8510102.0,
295,55457,4,1,,103207558,14710,Unspecified,,,,,Compound was tested for binding affinity constant for DNA,Other,,
296,72882,3,3,,103207558,14710,Unspecified,,,,,Thermal denaturation in alternating poly(dG-dC)-poly(dG-dC) homopolymer (GC),Other,8510102.0,
297,86067,8,3,,103207558,14710,Inconclusive,,,,,Compound was tested in vitro to inhibit 50% colon carcinoma HT-29 cell growth after 72 h; No data,Other,,
298,144987,9,2,,103207558,14710,Active,,,3.13,IC50,Tested for the binding of [3H]dizocilpine to DEPC (diethylpyrocarbonate) membranes of rat,Confirmatory,,
299,144988,9,3,,103207558,14710,Active,,,7.34,IC50,Tested for the binding of [3H]dizocilpine to NMDA receptor in rat brain membranes in the presence of 500 uM spermidine,Confirmatory,,
300,145118,6,1,,103207558,14710,Unspecified,,,,,Tested for the dissociation of [3H]dizocilpine binding at a concentration 3 uM,Other,,
301,145119,6,1,,103207558,14710,Unspecified,,,,,Tested for the dissociation of [3H]dizocilpine binding at a concentration 30 uM,Other,,
302,212907,9,2,,103207558,14710,Active,,,3.3,IC50,Inhibitory activity against telomerase (Compound released from DNA/DNA heteroduplex derivatized resin [sequence (TTAGGG)3),Confirmatory,11591511.0,
303,212908,9,2,,103207558,14710,Active,,,3.3,IC50,Inhibitory activity against telomerase (Compound released from RNA/DNA heteroduplex derivatized resin [sequence (TTAGGG)3),Confirmatory,11591511.0,
304,212909,9,2,,103207558,14710,Active,,,3.3,IC50,Inhibitory activity against telomerase (Compound released from underivatized resin,Confirmatory,11591511.0,
305,227385,3,4,,103207558,14710,Unspecified,,,,,Tested for the increase in [Ca2+] produced by 30 uM of the compound,Other,,
306,233938,3,3,,103207558,14710,Unspecified,,,,,Ratio between poly-dAdT and poly-dGdC binding,Other,8510102.0,
307,243248,7,1,,103207558,14710,Active,,,,,Ratio of maximum concentration bound and specificity sum for triplex nucleic acids,Other,15509172.0,
308,247965,6,2,,103207558,14710,Active,,,0.4,IC50,Concentration required to inhibit 50% of human carcinoma CH1 cell lines,Confirmatory,15501053.0,
309,248000,6,2,,103207558,14710,Active,,,0.1,IC50,Concentration required to inhibit 50% of human carcinoma A2780 cell lines,Confirmatory,15501053.0,
310,248001,6,2,,103207558,14710,Active,,,4.5,IC50,Concentration required to inhibit 50% of human carcinoma SKOV3 cell lines,Confirmatory,15501053.0,
311,283558,11,1,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli AG102 with marR1 mutation after 24 hrs,Other,17210767.0,
312,283559,11,1,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli AG102MB after 24 hrs,Other,17210767.0,
313,283560,11,1,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli HNCE4 after 24 hrs,Other,17210767.0,
314,285528,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus ATCC 29213 after 24 hrs by broth microdilution method,Other,17242152.0,
315,285529,7,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus ATCC 29213 in presence of 20 ug/ml reserpine after 24 hrs by broth microdilution method,Other,17242152.0,
316,285530,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus Mu50 after 24 hrs by broth microdilution method,Other,17242152.0,
317,285531,7,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus Mu50 in presence of 20 ug/ml reserpine after 24 hrs by broth microdilution method,Other,17242152.0,
318,285532,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus BSA643 after 24 hrs by broth microdilution method,Other,17242152.0,
319,285533,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus BSA678 after 24 hrs by broth microdilution method,Other,17242152.0,
320,339751,3,3,,103207558,14710,Unspecified,,,,,Binding affinity to synthetic poly(dA-dT):poly(dA-dT) DNA: DNA duplex assessed as melting temperature at 2.2 uM,Other,18573660.0,
321,339753,3,3,,103207558,14710,Unspecified,,,,,Binding affinity to synthetic poly(rA):poly(rU) RNA:RNA duplex assessed as melting temperature at 2.2 uM,Other,18573660.0,
322,339754,3,3,,103207558,14710,Unspecified,,,,,Binding affinity to synthetic poly(dA):poly(rU) DNA:RNA hybrid assessed as melting temperature at 2.2 uM,Other,18573660.0,
323,339764,8,1,,103207558,14710,Unspecified,,,,,Binding affinity to synthetic poly(dA):poly(rU) DNA:RNA hybrid assessed as association constant at 20 degC,Other,18573660.0,
324,339765,9,1,,103207558,14710,Unspecified,,,,,Binding affinity to synthetic poly(rA):poly(rU) DNA:RNA hybrid assessed as association constant at 20 degC,Other,18573660.0,
325,339766,10,1,,103207558,14710,Unspecified,,,,,Binding affinity to synthetic poly(dA-dT):poly(dA-dT) DNA:DNA duplex assessed as association constant at 20 degC,Other,18573660.0,
326,357845,4,4,,103207558,14710,Unspecified,,,,,Binding affinity to calf thymus DNA assessed as reduction in DNA peak by pre-incubation method,Other,1812211.0,
327,357846,4,4,,103207558,14710,Unspecified,,,,,Binding affinity to yeast tRNA assessed as reduction in tRNA peak by pre-incubation method,Other,1812211.0,
328,361640,3,3,,103207558,14710,Inactive,,,,,Inhibition of calf thymus topoisomerase 1 assessed as induction of supercoiled plasmid pCI DNA nicking at 10 uM after 30 mins by gel electrophoresis,Other,18652444.0,
329,366770,3,3,,103207558,14710,Active,,,,,Inhibition of calf thymus topoisomerase 1-mediated supercoiled plasmid pCI DNA relaxation activity at 10 uM after 30 mins by gel electrophoresis,Other,18652444.0,
330,368418,6,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Escherichia coli C316 pHPA containing mutated GyrA gene by agar dilution method,Other,17548499.0,
331,368419,6,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Escherichia coli KAM32 expressing deltaacrB ydhE hsd gene by agar dilution method,Other,17548499.0,
332,368420,6,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Escherichia coli KAM32 pHPA containing mutated GyrA gene by agar dilution method,Other,17548499.0,
333,368421,6,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Escherichia coli KAM32 pSTV28 containing chloramphenicol-resistant vector by agar dilution method,Other,17548499.0,
334,368422,6,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Escherichia coli KAM32 pSTVqepA containing qepA gene ligated to pSTV28 plasmid by agar dilution method,Other,17548499.0,
335,368423,6,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Escherichia coli KAM32 pSTVdeltaqepA containing disrupted qepA gene by agar dilution method,Other,17548499.0,
336,368424,3,3,,103207558,14710,Unspecified,,,,,Ratio of MIC for Escherichia coli KAM32 pSTVqepA mutant to MIC for Escherichia coli KAM32 pSTV28 mutant,Other,17548499.0,
337,368915,6,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against methicillin-resistant Staphylococcus aureus effluxing isolate,Other,17576828.0,
338,368918,3,6,,103207558,14710,Unspecified,,,,,Inhibition of multidrug-resistant efflux pump in methicillin-resistant Staphylococcus aureus effluxing isolate assessed as fold reduction of ethidium-bromide MIC at 10 ug/ml by microdilution method,Other,17576828.0,
339,374687,6,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus NCTC 8325-4 expressing NorA gene,Other,17664318.0,
340,374688,6,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against NorA deficient Staphylococcus aureus K1758,Other,17664318.0,
341,374689,6,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against totarol-resistant Staphylococcus aureus K3090,Other,17664318.0,
342,374690,6,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus K3092 overexpressing NorA gene,Other,17664318.0,
343,388885,3,3,,103207558,14710,Active,,,,,DNA intercalative activity assessed retardation in migration of negatively supercoiled small circular Escherichia coli pBSKS in agarose gel electrophoresis at 100 uM,Other,18816045.0,
344,395135,3,4,,103207558,14710,Unspecified,,,,,Binding affinity to poly(A).poly(U) RNA assessed as change in melting temperature,Other,18403056.0,
345,396042,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against drug-resistant Enterobacter cloacae EcDC64 isolate expressing AcrAB-TolC efflux pump by broth microdilution method,Other,17638702.0,
346,396280,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate by broth microdilution method,Other,17638702.0,
347,396281,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pBGS18 plasmid by broth microdilution method,Other,17638702.0,
348,396282,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pAP2 plasmid containing Enterobacter cloacae acrA gene by broth microdilution method,Other,17638702.0,
349,396283,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pACYC184 plasmid by broth microdilution method,Other,17638702.0,
350,396284,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pAP3 plasmid containing Enterobacter aerogenes acrR gene by broth microdilution method,Other,17638702.0,
351,405367,3,4,,103207558,14710,Unspecified,,,,,Toxicity against human sHepG2/C3A cells assessed as reduction in mitochondrial DNA copy numbers at 0.5 ug/ml after 6 days relative to control,Other,17470651.0,
352,405368,3,4,,103207558,14710,Unspecified,,,,,Toxicity against human H9c2 cells assessed as reduction in mitochondrial DNA copy numbers at 0.5 ug/ml after 6 days relative to control,Other,17470651.0,
353,405369,3,3,,103207558,14710,Unspecified,,,,,Toxicity in human HepG2/C3A cells assessed as cell viability at 0.5 ug/ml after 10 days,Other,17470651.0,
354,405370,3,3,,103207558,14710,Unspecified,,,,,Toxicity in human HepG2/C3A cells assessed as cell viability at 0.5 ug/ml after 14 days,Other,17470651.0,
355,405371,3,4,,103207558,14710,Unspecified,,,,,Toxicity in human sH9c2 cells assessed as cell viability at 0.5 ug/ml after 10 to 14 days,Other,17470651.0,
356,405372,3,4,,103207558,14710,Unspecified,,,,,Toxicity against human HepG2/C3A cells assessed as inhibition of cell proliferation at 0.5 ug/ml after 6 days by SRB assay,Other,17470651.0,
357,405373,3,4,,103207558,14710,Unspecified,,,,,Toxicity against human H9c2 cells assessed as inhibition of cell proliferation at 0.5 ug/ml after 6 days by SRB assay,Other,17470651.0,
358,405374,3,4,,103207558,14710,Unspecified,,,,,Toxicity against human HepG2/C3A cells assessed as elevation of lactate levels at 0.5 ug/ml after 6 days by NAD+ reduction assay,Other,17470651.0,
359,405375,3,4,,103207558,14710,Unspecified,,,,,Toxicity against human H9c2 cells assessed as elevation of lactate levels at 0.5 ug/ml after 6 days by NAD+ reduction assay,Other,17470651.0,
360,405376,3,4,,103207558,14710,Unspecified,,,,,Toxicity against human HepG2/C3A cells assessed as increase in mitochondrial superoxide production at 0.5 ug/ml after 4 to 14 days by flow cytometry,Other,17470651.0,
361,405377,3,4,,103207558,14710,Unspecified,,,,,Toxicity against human H9c2 cells assessed as increase in mitochondrial superoxide production at 0.5 ug/ml after 4 to 14 days by flow cytometry,Other,17470651.0,
362,405378,3,4,,103207558,14710,Unspecified,,,,,Toxicity against human HepG2/C3A cells assessed as reduction in mitochondrial DNA copy numbers at 0.5 ug/ml after 4 days relative to control,Other,17470651.0,
363,405379,3,4,,103207558,14710,Unspecified,,,,,Toxicity against human HepG2/C3A cells assessed as reduction in mitochondrial DNA copy numbers at 0.5 ug/ml after 10 days relative to control,Other,17470651.0,
364,405380,3,4,,103207558,14710,Unspecified,,,,,Toxicity against human HepG2/C3A cells assessed as reduction in mitochondrial DNA copy numbers at 0.5 ug/ml after 14 days relative to control,Other,17470651.0,
365,405381,3,4,,103207558,14710,Unspecified,,,,,Toxicity against human H9c2 cells assessed as reduction in mitochondrial DNA copy numbers at 0.5 ug/ml after 12 days relative to control,Other,17470651.0,
366,405454,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli C600Rif by Etest,Other,17470656.0,
367,405456,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli C600Rif in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,Other,17470656.0,
368,405457,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli C600Rif in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,Other,17470656.0,
369,405458,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid by Etest,Other,17470656.0,
370,405459,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,Other,17470656.0,
371,405460,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,Other,17470656.0,
372,405461,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli TOP10 by Etest,Other,17470656.0,
373,405462,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli TOP10 in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,Other,17470656.0,
374,405463,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli TOP10 in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,Other,17470656.0,
375,405464,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid by Etest,Other,17470656.0,
376,405465,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,Other,17470656.0,
377,405466,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,Other,17470656.0,
378,405467,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli TOP10 containing pAT851 plasmid by Etest,Other,17470656.0,
379,405468,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli TOP10 containing pAT851 in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,Other,17470656.0,
380,405469,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli TOP10 containing pAT851 in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,Other,17470656.0,
381,406646,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by broth microdilution method,Other,17502409.0,
382,406647,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus ACH-0204 isolate with gyrA Ser84Leu mutant after 24 hrs by broth microdilution method,Other,17502409.0,
383,406648,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus ACH-0206 isolate with gyrA Ser84Leu mutant after 24 hrs by broth microdilution method,Other,17502409.0,
384,406649,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus ACH-0221 isolate with gyrA Ser84Leu mutant after 24 hrs by broth microdilution method,Other,17502409.0,
385,406650,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus ACH-0216 isolate with grlA Ser80Phe mutant after 24 hrs by broth microdilution method,Other,17502409.0,
386,406651,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus ACH-0218 isolate with grlA Glu84Lys mutant after 24 hrs by broth microdilution method,Other,17502409.0,
387,406652,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus ACH-0126 isolate with gyrA Ser84Leu and grlA Ser80Phe mutant after 24 hrs by broth microdilution method,Other,17502409.0,
388,406653,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus ACH-0210 isolate with gyrA Ser84Leu and grlA Ser80Phe mutant after 24 hrs by broth microdilution method,Other,17502409.0,
389,406654,6,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Staphylococcus aureus ACH-0186 isolate with gyrA Ser84Leu and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",Other,17502409.0,
390,406655,6,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Staphylococcus aureus ACH-0192 isolate with gyrA Ser84Leu and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",Other,17502409.0,
391,406656,6,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Staphylococcus aureus ACH-0203 isolate with gyrA Ser84Leu and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",Other,17502409.0,
392,406657,6,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Staphylococcus aureus ACH-0129 isolate with gyrA Ser84Leu, Glu88Val and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",Other,17502409.0,
393,406658,6,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Staphylococcus aureus ACH-0129 isolate with gyrA Ser84Leu, Glu88Val and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",Other,17502409.0,
394,406806,6,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Staphylococcus aureus ACH-0201 isolate with gyrA Ser84Leu, Glu88Val and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",Other,17502409.0,
395,406807,6,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Staphylococcus aureus ACH-0141 isolate with gyrA Ser84Leu, Glu88Val and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",Other,17502409.0,
396,406808,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus ATCC 33591 isolate after 24 hrs by broth microdilution method,Other,17502409.0,
397,406809,6,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus NY2746 isolate with gyrA Ser84Leu and grlA Ser80Phe mutant after 24 hrs by broth microdilution method,Other,17502409.0,
398,406810,6,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Staphylococcus aureus ATCC 700699 isolate with gyrA Ser84Leu, Glu409Lys and grlA Ser80Phe mutant after 24 hrs by broth microdilution method",Other,17502409.0,
399,406811,6,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Staphylococcus aureus BSA643 isolate with gyrA Ser84Leu and grlA Ser80Tyr, Glu84Gly mutant after 24 hrs by broth microdilution method",Other,17502409.0,
400,406812,6,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Staphylococcus aureus BSA678 isolate with gyrA Ser84Leu, Ser85Pro and grlA Ser80Phe, Glu84Gly mutant after 24 hrs by broth microdilution method",Other,17502409.0,
401,406813,6,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Staphylococcus aureus ACH-0231 isolate with gyrA Ser84Leu, Glu88Lys and grlA Ser80Tyr, Glu84Gly mutant after 24 hrs by broth microdilution method",Other,17502409.0,
402,472809,5,2,,103207558,14710,Active,,,0.81,IC50,Inhibition of HCV genotype 1b NS5B polymerase deltaC21 mutant,Confirmatory,20363140.0,
403,472812,5,3,,103207558,14710,Active,,,0.7,CC50,Cytotoxicity against human HBI10A cells,Confirmatory,20363140.0,
404,472813,5,2,,103207558,14710,Active,,,0.6,EC50,Antiviral activity against Hepatitis C virus H2B2,Confirmatory,20363140.0,
405,472814,3,3,,103207558,14710,Unspecified,,,,,"Selectivity index, ratio of CC50 for human HBI10A cells to EC50 for Hepatitis C virus",Other,20363140.0,
406,472816,5,2,,103207558,14710,Active,,,3.8,IC50,Inhibition of HCV genotype 1b NS5B polymerase deltaC21 M423K mutant,Confirmatory,20363140.0,
407,485281,1,1,,26748838,14710,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
408,485290,1,1,,17389015,14710,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
409,485290,1,1,,26748838,14710,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
410,485350,1,2,,92124732,14710,Inactive,126642418.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme BasE,Screening,,
411,487000,3,3,,103207558,14710,Unspecified,,,,,Binding affinity to calf thymus DNA assessed as ratio of final absorbance area to the absorbance at 100 uM after 24 hrs by UV spectrophotometer analysis relative to control,Other,20471844.0,
412,488839,1,1,,92764758,14710,Inactive,20072248.0,8851.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
413,488839,1,1,,92764758,14710,Inactive,48146199.0,1020.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
414,488862,1,1,,92764758,14710,Inactive,,,,,Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
415,488895,1,2,,92764758,14710,Inactive,90111653.0,948321.0,,,High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
416,488896,1,1,,92764758,14710,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
417,488965,1,2,,92764758,14710,Inactive,218891639.0,,,,Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination - 2091-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
418,488966,1,1,,92764758,14710,Inactive,,,,IC50,Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis,Confirmatory,,
419,489406,8,5,,103207558,14710,Unspecified,6226780.0,7015.0,,IC50,Inhibition of human telomerase in human SGC7901 cells by TRAP assay,Confirmatory,20538457.0,
420,492953,1,1,,92764758,14710,Active,296080766.0,5049.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2)",Screening,,
421,492956,1,1,,92764758,14710,Active,4758878.0,5051.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2),Screening,,
422,492961,1,1,,17389015,14710,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase: hit validation,Confirmatory,,
423,492961,1,1,,26748838,14710,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase: hit validation,Confirmatory,,
424,492967,1,2,,99302028,14710,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
425,492972,1,1,,92764758,14710,Active,225543099.0,5050.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3)",Screening,,
426,493005,1,1,,92764758,14710,Inactive,5454140.0,7251.0,,Potency,qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
427,493008,1,1,,92764758,14710,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
428,493008,1,1,,92764758,14710,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
429,493008,1,1,,92764758,14710,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
430,493008,1,1,,92764758,14710,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
431,493033,1,2,,92124732,14710,Inactive,614089026.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme MbtI,Other,,
432,493073,1,1,,92764758,14710,Active,40807040.0,4286.0,2.42,AC50_uM,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_DoseNoFile_CherryPick_Activity_Set3,Confirmatory,,
433,493087,1,1,,92764758,14710,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE),Screening,,
434,493091,1,1,,92764758,14710,Inactive,10864009.0,58190.0,,,uHTS Colorimetric assay for identification of inhibitors of Scp-1,Screening,,
435,493098,1,1,,92764758,14710,Inactive,37187860.0,1235.0,,,uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay,Screening,,
436,493102,1,1,,92764758,14710,Active,40807040.0,4286.0,2.42,AC50_uM,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_DoseNoFile_CherryPick_Activity_Set4,Confirmatory,,
437,493131,1,1,,92764758,14710,Inactive,6679827.0,14282.0,,,Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity,Screening,,
438,493160,1,1,,92764758,14710,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing  I (HKDC1),Screening,,
439,493162,1,2,,99302028,14710,Active,335756.0,,,,A screen for compounds that inhibit processive DNA synthesis of vaccinia virus,Other,,
440,493177,2,2,,92764758,14710,Active,40807040.0,4286.0,2.42,AC50_uM,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_DoseNoFile_CherryPick_Activity_Set2,Confirmatory,,
441,493187,1,2,,92764758,14710,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of activators of hexokinase domain containing  I (HKDC1),Screening,,
442,493191,1,1,,92764758,14710,Active,40807040.0,4286.0,23.299,AC50_uM,MITF Orthogonal Assay: MALME3 CTG Assay Measured in Cell-Based System Using Plate Reader - 2084-04_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
443,493240,1,1,,92764758,14710,Active,40807040.0,4286.0,15.020999999999999,AC50_uM,MITF Orthogonal Assay: SK-MEL-5 CTG Assay Measured in Cell-Based System Using Plate Reader - 2084-02_Inhibitor_Dose_CherryPick_Activity_Set3,Confirmatory,,
444,493244,1,1,,92764758,14710,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
445,493244,1,1,,92764758,14710,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
446,493244,1,1,,92764758,14710,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
447,493244,1,1,,92764758,14710,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
448,498873,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Neisseria meningitidis M7 by agar dilution method,Other,19884363.0,
449,498874,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Neisseria meningitidis M7tolC::Kan by agar dilution method,Other,19884363.0,
450,498875,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Neisseria meningitidis M7mtrE::Spc by agar dilution method,Other,19884363.0,
451,498876,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Neisseria meningitidis M7tolC::Kan mtr::Spc by agar dilution method,Other,19884363.0,
452,498877,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Escherichia coli RAM4100 by agar dilution method,Other,19884363.0,
453,498878,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Escherichia coli RAM1129 by agar dilution method,Other,19884363.0,
454,498879,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Escherichia cloi RAM1129 transfected with pGCC4 containg IPTG-inducible lacZ promoter by agar dilution method,Other,19884363.0,
455,498880,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Escherichia cloi RAM1129 transfected with pNK1 containg Neisseria meningitidis tolC gene by agar dilution method,Other,19884363.0,
456,504326,1,2,,92764758,14710,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
457,504326,1,2,,92764758,14710,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
458,504327,1,1,,17389015,14710,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
459,504327,1,1,,26748838,14710,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
460,504329,1,1,,92764758,14710,Inactive,227977143.0,23308111.0,,IC50,Discovery of Small Molecule Probes for H1N1 Influenza NS1A,Confirmatory,,
461,504332,1,1,,17389015,14710,Inconclusive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
462,504332,1,1,,26748838,14710,Inconclusive,168985070.0,,2.8184,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
463,504339,1,1,,92764758,14710,Inconclusive,162330054.0,,50.1187,Potency,qHTS Assay for Inhibitors of JMJD2A-Tudor Domain,Confirmatory,,
464,504357,1,1,,92764758,14710,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
465,504357,1,1,,92764758,14710,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
466,504370,1,1,,17389015,14710,Active,13124873.0,865.0,10.0,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: ME-1 cellular proliferation,Confirmatory,,
467,504370,1,1,,17389015,14710,Active,49574546.0,861.0,10.0,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: ME-1 cellular proliferation,Confirmatory,,
468,504374,2,1,,17389015,14710,Active,13124873.0,865.0,0.4992,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation,Confirmatory,,
469,504374,2,1,,17389015,14710,Active,49574546.0,861.0,0.4992,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation,Confirmatory,,
470,504375,1,2,,17389015,14710,Inconclusive,13124873.0,865.0,22.2971,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation with Orthogonal Assay,Confirmatory,,
471,504375,1,2,,17389015,14710,Inconclusive,49574546.0,861.0,22.2971,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation with Orthogonal Assay,Confirmatory,,
472,504408,2,1,,92764758,14710,Inactive,,,,,Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity,Screening,,
473,504411,1,1,,92764758,14710,Inactive,218931251.0,221955.0,,,"Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of human diacylglycerol lipase, beta (DAGLB)",Screening,,
474,504414,1,1,,92764758,14710,Inactive,9966877.0,57120.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
475,504414,1,1,,92764758,14710,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
476,504423,1,1,,92764758,14710,Inactive,312275222.0,,,,C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
477,504441,1,1,,92764758,14710,Inactive,6978787.0,25255.0,,,Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
478,504444,1,1,,92764758,14710,Active,224028257.0,4780.0,14.581,Potency,Nrf2 qHTS screen for inhibitors,Confirmatory,,
479,504454,1,3,,92764758,14710,Inactive,4501969.0,154.0,,,HTS for Beta-2AR agonists via FAP method,Screening,,
480,504462,1,1,,92764758,14710,Inactive,47132611.0,23192.0,,,uHTS fluorescent assay for identification of inhibitors of ATG4B,Screening,,
481,504490,1,2,,92764758,14710,Inactive,13177715.0,408.0,,,Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction That Mediate GPCR Degradation and Recycling,Screening,,
482,504523,1,1,,92764758,14710,Inactive,45269145.0,9817.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
483,504523,1,1,,92764758,14710,Inactive,224028257.0,4780.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
484,504558,1,1,,92764758,14710,Inactive,23893668.0,3783750.0,,,Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
485,504577,2,2,,92764758,14710,Inactive,6325022.0,855842.0,,,HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin,Screening,,
486,504582,2,1,,92764758,14710,Inactive,124809271.0,811941.0,,,In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
487,504621,1,1,,92764758,14710,Inactive,124809506.0,811999.0,,,Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
488,504634,1,1,,92764758,14710,Inactive,13236497.0,3361.0,,,Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
489,504648,1,1,,92764758,14710,Inconclusive,,,12.9953,Potency,Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity,Confirmatory,,
490,504690,1,3,,92764758,14710,Inactive,12381848.0,,,,uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay,Screening,,
491,504692,2,2,,92764758,14710,Inactive,13236497.0,3361.0,,,Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
492,504700,1,1,,92764758,14710,Inactive,46909587.0,5567.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
493,504700,1,1,,92764758,14710,Inactive,47132585.0,5577.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
494,504707,1,1,,92764758,14710,Inactive,6755076.0,18749.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
495,504707,1,1,,92764758,14710,Inactive,115496662.0,615074.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
496,504720,1,1,,92764758,14710,Inactive,16130689.0,947252.0,,,uHTS identification of MazEF TA System activators  via a fluorescence-based single-stranded RNase assay,Screening,,
497,504734,1,1,,92764758,14710,Inactive,194068499.0,54106.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding.,Screening,,
498,504749,1,3,,17389015,14710,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
499,504749,1,3,,26748838,14710,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
500,504749,1,3,1.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
501,504749,1,3,1.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
502,504749,1,3,2.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
503,504749,1,3,2.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
504,504749,1,3,3.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
505,504749,1,3,3.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
506,504749,1,3,4.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
507,504749,1,3,4.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
508,504749,1,3,5.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
509,504749,1,3,5.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
510,504749,1,3,6.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
511,504749,1,3,6.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
512,504749,1,3,7.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
513,504749,1,3,7.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
514,504749,1,3,8.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
515,504749,1,3,8.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
516,504749,1,3,9.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
517,504749,1,3,9.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
518,504749,1,3,10.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
519,504749,1,3,10.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
520,504749,1,3,11.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
521,504749,1,3,11.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
522,504749,1,3,12.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
523,504749,1,3,12.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
524,504749,1,3,13.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
525,504749,1,3,13.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
526,504749,1,3,14.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
527,504749,1,3,14.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
528,504749,1,3,15.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
529,504749,1,3,15.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
530,504749,1,3,16.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
531,504749,1,3,16.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
532,504749,1,3,17.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
533,504749,1,3,17.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
534,504749,1,3,18.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
535,504749,1,3,18.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
536,504749,1,3,19.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
537,504749,1,3,19.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
538,504749,1,3,20.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
539,504749,1,3,20.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
540,504749,1,3,21.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
541,504749,1,3,21.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
542,504749,1,3,22.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
543,504749,1,3,22.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
544,504749,1,3,23.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
545,504749,1,3,23.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
546,504749,1,3,24.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
547,504749,1,3,24.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
548,504749,1,3,25.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
549,504749,1,3,25.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
550,504749,1,3,26.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
551,504749,1,3,26.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
552,504749,1,3,27.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
553,504749,1,3,27.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
554,504749,1,3,28.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
555,504749,1,3,28.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
556,504749,1,3,29.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
557,504749,1,3,29.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
558,504749,1,3,30.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
559,504749,1,3,30.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
560,504749,1,3,31.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
561,504749,1,3,31.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
562,504749,1,3,32.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
563,504749,1,3,32.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
564,504749,1,3,33.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
565,504749,1,3,33.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
566,504749,1,3,34.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
567,504749,1,3,34.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
568,504749,1,3,35.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
569,504749,1,3,35.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
570,504749,1,3,36.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
571,504749,1,3,36.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
572,504749,1,3,37.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
573,504749,1,3,37.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
574,504749,1,3,38.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
575,504749,1,3,38.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
576,504749,1,3,39.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
577,504749,1,3,39.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
578,504749,1,3,40.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
579,504749,1,3,40.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
580,504749,1,3,41.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
581,504749,1,3,41.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
582,504749,1,3,42.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
583,504749,1,3,42.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
584,504749,1,3,43.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
585,504749,1,3,43.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
586,504749,1,3,44.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
587,504749,1,3,44.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
588,504749,1,3,45.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
589,504749,1,3,45.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
590,504749,1,3,46.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
591,504749,1,3,46.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
592,504749,1,3,47.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
593,504749,1,3,47.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
594,504749,1,3,48.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
595,504749,1,3,48.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
596,504749,1,3,49.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
597,504749,1,3,49.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
598,504749,1,3,50.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
599,504749,1,3,50.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
600,504749,1,3,51.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
601,504749,1,3,51.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
602,504749,1,3,52.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
603,504749,1,3,52.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
604,504749,1,3,53.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
605,504749,1,3,53.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
606,504749,1,3,54.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
607,504749,1,3,54.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
608,504749,1,3,55.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
609,504749,1,3,55.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
610,504749,1,3,56.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
611,504749,1,3,56.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
612,504749,1,3,57.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
613,504749,1,3,57.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
614,504749,1,3,58.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
615,504749,1,3,58.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
616,504749,1,3,59.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
617,504749,1,3,59.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
618,504749,1,3,60.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
619,504749,1,3,60.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
620,504749,1,3,61.0,17389015,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
621,504749,1,3,61.0,26748838,14710,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
622,504766,2,1,,92764758,14710,Inactive,5016090.0,190.0,,,"Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1)",Screening,,
623,504770,1,2,,92124732,14710,Inactive,9657380.0,2612528.0,,,A screen for compounds that inhibit replication of Vibrio cholerae chromosome II,Other,,
624,504775,1,1,,92764758,14710,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Activator_SinglePoint_HTS_Activity,Screening,,
625,504803,1,1,,92764758,14710,Active,121945198.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1),Screening,,
626,504832,1,1,,17389015,14710,Active,,,0.019,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
627,504832,1,1,,26748838,14710,Active,,,0.0478,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
628,504834,1,1,,17389015,14710,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
629,504834,1,1,,26748838,14710,Active,,,0.003,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
630,504845,1,1,,92764758,14710,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
631,504847,1,1,,17389015,14710,Active,63054845.0,7421.0,10.0,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
632,504847,1,1,,26748838,14710,Active,63054845.0,7421.0,19.9526,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
633,504847,1,1,,92764758,14710,Inconclusive,63054845.0,7421.0,100.0,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
634,504848,1,1,,26748838,14710,Active,,,0.0282,Potency,"Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
635,504850,1,1,,26748838,14710,Active,,,1.0,Potency,"Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
636,504865,1,1,,17389015,14710,Inconclusive,118600387.0,7398.0,25.1189,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
637,504865,1,1,,26748838,14710,Active,118600387.0,7398.0,39.8107,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
638,504884,1,2,,92764758,14710,Inactive,115347926.0,1175052.0,,,Inhibitors of Y. pestis Topo-I using cleavage product accumulation Measured in Biochemical System Using Plate Reader - 2123-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
639,504891,1,1,,92764758,14710,Inconclusive,5453898.0,5300.0,75.6863,Potency,qHTS Assay to Find Inhibitors of Pin1,Confirmatory,,
640,504894,1,1,,92764758,14710,Inactive,553160.0,,,Potency,Activators of T cell receptors: qHTS campaign,Confirmatory,,
641,504937,1,2,,92764758,14710,Inactive,179095.0,6609.0,,Potency,Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS,Confirmatory,,
642,510559,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli AG102MB,Other,20038628.0,
643,510747,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli AG102MB harboring pSport1-based acrB gene,Other,20038628.0,
644,510748,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli AG102MB harboring naive acrB gene,Other,20038628.0,
645,510749,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli AG102MB harboring pP10-based acrB gene,Other,20038628.0,
646,510750,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli AG102MB harboring pS1328-based acrB gene,Other,20038628.0,
647,512633,2,3,,103207558,14710,Active,,,,,Binding affinity to human c-MYC Pu24I G-quadruplex structure assessed as stabilization of G-quadruplex by NMR spectroscopy,Other,16408022.0,
648,516696,7,5,,103207558,14710,Active,6226780.0,7015.0,2.5,IC50,Inhibition of telomerase in human SGC7901 cells by TRAP assay,Confirmatory,20800480.0,
649,519833,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Aeromonas hydrophila subsp. hydrophila ATCC 7966 harboring plasmid pEX19Gm by agar dilution method in presence of 64 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,Other,18268083.0,
650,519834,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against aheB deficient kanamycin-resistant Aeromonas hydrophila subsp. hydrophila ATCC 7966 harboring plasmid pEX19Gm by agar dilution method,Other,18268083.0,
651,520081,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against aheB deficient kanamycin-resistant Aeromonas hydrophila subsp. hydrophila ATCC 7966 harboring plasmid pEX19Gm by agar dilution method in presence of 64 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,Other,18268083.0,
652,520082,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against aheB deficient kanamycin-resistant Aeromonas hydrophila subsp. hydrophila ATCC 7966 harboring AheABC efflux pump by agar dilution method,Other,18268083.0,
653,520083,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against aheB-deficient kanamycin-resistant Aeromonas hydrophila subsp. hydrophila ATCC 7966 harboring AheABC efflux pump by agar dilution method in presence of 64 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,Other,18268083.0,
654,520084,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Escherichia coli TG1 harboring plasmid pEX19Gm by agar dilution method,Other,18268083.0,
655,520085,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against acrAB-deficient Escherichia coli TG1 harboring plasmid pEX19Gm by agar dilution method,Other,18268083.0,
656,520086,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against acrAB-deficient Escherichia coli TG1 harboring AcrAB efflux pump by agar dilution method,Other,18268083.0,
657,520087,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against acrAB-deficient Escherichia coli TG1 harboring AheABC efflux pump by agar dilution method,Other,18268083.0,
658,520088,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Aeromonas hydrophila subsp. hydrophila ATCC 7966 harboring plasmid pEX19Gm by agar dilution method,Other,18268083.0,
659,523165,2,3,,103207558,14710,Active,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate OC8525 harboring wild type quinolone resistance-determining region assessed as >= 4 fold increase in bactericidal activity by broth microdilution method in presence of 20 ug/ml reserpine,Other,20176911.0,
660,523166,2,3,,103207558,14710,Active,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate OC11696 assessed as >= 4 fold increase in bactericidal activity by broth microdilution method in presence of 20 ug/ml reserpine,Other,20176911.0,
661,523167,2,3,,103207558,14710,Active,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate OC12501 assessed as >= 4 fold increase in bactericidal activity by broth microdilution method in presence of 20 ug/ml reserpine,Other,20176911.0,
662,523168,2,3,,103207558,14710,Active,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate OC8530 harboring gyrA S84L and parC I143V mutant gene assessed as >= 4 fold increase in bactericidal activity by broth microdilution method in presence of 20 ug/ml reserpine,Other,20176911.0,
663,523169,2,3,,103207558,14710,Active,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate OC4222 harboring gyrA S84L and parC S80F mutant gene assessed as >= 4 fold increase in bactericidal activity by broth microdilution method in presence of 20 ug/ml reserpine,Other,20176911.0,
664,523170,2,3,,103207558,14710,Active,,,,,"Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate OC17042 harboring gyrA S84L/G106D, parC S80F and parE D732N mutant gene assessed as >= 4 fold increase in bactericidal activity by broth microdilution method in presence of 20 ug/ml reserpine",Other,20176911.0,
665,523171,2,3,,103207558,14710,Active,,,,,"Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate OC11521 harboring gyrA S84L/S85P, parC E84G mutant gene assessed as >= 4 fold increase in bactericidal activity by broth microdilution method in presence of 20 ug/ml reserpine",Other,20176911.0,
666,532573,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 by broth dilution method,Other,18694955.0,
667,532580,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph mutant by broth dilution method,Other,18694955.0,
668,532581,5,4,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Typhimurium LT2 by broth dilution method,Other,18694955.0,
669,532582,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Typhimurium 14028S by broth dilution method,Other,18694955.0,
670,532583,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Binza 8269 by broth dilution method,Other,18694955.0,
671,532584,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Enteritidis 5188 by broth dilution method,Other,18694955.0,
672,532754,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Hadar by broth dilution method,Other,18694955.0,
673,532755,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Heidelberg 5171 by broth dilution method,Other,18694955.0,
674,532756,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Haifa 9878 by broth dilution method,Other,18694955.0,
675,532757,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Kedougou by broth dilution method,Other,18694955.0,
676,532758,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Mbandaka 7892 by broth dilution method,Other,18694955.0,
677,532759,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Montevideo 5747 by broth dilution method,Other,18694955.0,
678,532760,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Newport 129 by broth dilution method,Other,18694955.0,
679,532761,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Virchow 5742 by broth dilution method,Other,18694955.0,
680,532762,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 by broth dilution method in presence of chlorpromazine,Other,18694955.0,
681,532763,2,4,,103207558,14710,Inconclusive,,,,,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph mutant by broth dilution method in presence of chlorpromazine,Other,18694955.0,
682,532764,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph-pTRC hisA:ramA mutant by broth dilution method,Other,18694955.0,
683,532765,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph-pTRC hisA:ramA mutant by broth dilution method in presence of IPTG,Other,18694955.0,
684,532766,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph-pTRC hisA:ramA mutant by broth dilution method in presence of chlorpromzine,Other,18694955.0,
685,534106,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Pasteurella multocida AL435 after 24 hrs by broth dilution method,Other,18725450.0,
686,534107,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against TolC deficient Pasteurella multocida pm0527 after 24 hrs by broth dilution method,Other,18725450.0,
687,534108,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Pasteurella multocida pm0527 after 24 hrs by broth dilution method,Other,18725450.0,
688,534109,1,3,,103207558,14710,Unspecified,,,,,Ratio of MIC for Pasteurella multocida AL435 to MIC for TolC deficient Pasteurella multocida pm0527,Other,18725450.0,
689,534110,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against TolC deficient Pasteurella multocida pm1980 after 24 hrs by broth dilution method,Other,18725450.0,
690,534111,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Pasteurella multocida pm1980 after 24 hrs by broth dilution method,Other,18725450.0,
691,534112,1,3,,103207558,14710,Unspecified,,,,,Ratio of MIC for Pasteurella multocida AL435 to MIC for TolC deficient Pasteurella multocida pm1980,Other,18725450.0,
692,537601,7,5,,103207558,14710,Active,6226780.0,7015.0,2.5,IC50,Inhibition of telomerase in human SGC7901 cells by TRAP assay,Confirmatory,20947362.0,
693,538150,1,4,,103207558,14710,Unspecified,,,,,Binding affinity to calf thymus DNA assessed as ratio of final absorbance area to absorbance of compound at 100 uM after 24 hrs by UV spectrophotometer analysis,Other,20846761.0,
694,540248,1,1,,92764758,14710,Active,121945198.0,,,,Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the HTRA serine peptidase 1 (HTRA1),Other,,
695,540253,1,1,,92764758,14710,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
696,540253,1,1,,92764758,14710,Inactive,5453555.0,5901.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
697,540253,1,1,,92764758,14710,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
698,540256,1,2,,92764758,14710,Inconclusive,,,7.9433,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
699,540263,1,1,,92764758,14710,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
700,540263,1,1,,92764758,14710,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
701,540267,1,1,,92764758,14710,Inactive,,,,,Small Molecules that selectively kill Giardia lamblia: qHTS,Screening,,
702,540276,1,2,,92764758,14710,Inconclusive,420597.0,,10.0,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
703,540295,1,1,,92764758,14710,Inactive,119508433.0,4160.0,,,TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R,Screening,,
704,540299,1,2,,92124732,14710,Inactive,15607688.0,887529.0,,,A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis,Other,20850304.0,
705,540303,1,1,,92764758,14710,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
706,540303,1,1,,92764758,14710,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
707,540303,1,1,,92764758,14710,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
708,540308,1,1,,92764758,14710,Inactive,119508433.0,4160.0,,,Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R,Screening,,
709,540317,1,1,,92764758,14710,Inconclusive,187960037.0,10951.0,70.7946,Potency,HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
710,540335,1,1,,92764758,14710,Inactive,,,,AC50_uM,MITF: Counter assay: A375 proliferation Measured in Cell-Based System Using Plate Reader - 2084-03_Inhibitor_Dose_CherryPick_Activity_Set2,Confirmatory,,
711,540336,1,1,,92764758,14710,Inactive,68474550.0,3639678.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
712,540336,1,1,,92764758,14710,Inactive,68488893.0,3646682.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
713,540346,1,1,,92764758,14710,Inactive,40807040.0,4286.0,,AC50_uM,MITF: Counter assay: A375 proliferation Measured in Cell-Based System Using Plate Reader - 2084-03_Inhibitor_Dose_DryPowder_Activity,Confirmatory,,
714,540364,1,2,,92764758,14710,Inactive,,2395.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter,Screening,,
715,572147,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBADomeganorM plasmid containing Neisseria gonorrhoeae multidrug efflux pump NorM after 18 to 24 hrs by two fold dilution method,Other,18591276.0,
716,572148,2,10,,103207558,14710,Active,2507511.0,,,,Activity of Escherichia coli K-12 multidrug efflux protein YdhE expressed in Escherichia coli AG100AX assessed as reduction in compound accumulation by fluorimetric assay,Other,18591276.0,
717,572149,2,3,,103207558,14710,Active,,,,,Activity of Neisseria gonorrhoeae FA19 multidrug efflux protein NorM expressed in Escherichia coli AG100AX assessed as reduction in compound accumulation by fluorimetric assay,Other,18591276.0,
718,572150,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBAD plasmid after 18 to 24 hrs by two fold dilution method,Other,18591276.0,
719,572151,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBADomegaydhE plasmid containing Escherichia coli multidrug efflux pump YdhE after 18 to 24 hrs by two fold dilution method,Other,18591276.0,
720,572156,2,3,,103207558,14710,Active,,,,,Activity of Neisseria gonorrhoeae FA19 multidrug efflux protein NorM expressed in Escherichia coli AG100AX assessed as reduction in compound accumulation in presence of 100 mM NaCl by fluorimetric assay,Other,18591276.0,
721,572157,4,2,,103207558,14710,Active,,,12.3,Kd,Binding affinity to Neisseria gonorrhoeae FA19 multidrug efflux protein NorM expressed in Escherichia coli AG100AX in presence of 0.02% DDM surfactant by fluorescence polarization assay,Confirmatory,18591276.0,
722,572158,7,5,,103207558,14710,Active,2507511.0,,9.8,Kd,Binding affinity to Escherichia coli K-12 multidrug efflux protein YdhE expressed in Escherichia coli AG100AX in presence of 0.02% DDM surfactant by fluorescence polarization assay,Confirmatory,18591276.0,
723,576014,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZN10 containing cat and bla genes by agar dilution method,Other,20660673.0,
724,576015,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2396-encoded QacA gene by agar dilution method,Other,20660673.0,
725,576016,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2182-encoded QacBII gene by agar dilution method,Other,20660673.0,
726,576017,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2162-encoded QacBIII gene by agar dilution method,Other,20660673.0,
727,576018,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2162-encoded QacBIII E320A mutant gene by agar dilution method,Other,20660673.0,
728,576019,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV gene by agar dilution method,Other,20660673.0,
729,576020,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV A19T mutant gene by agar dilution method,Other,20660673.0,
730,576021,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV S151I mutant gene by agar dilution method,Other,20660673.0,
731,576022,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV A184V mutant gene by agar dilution method,Other,20660673.0,
732,576023,5,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV E377G mutant gene by agar dilution method,Other,20660673.0,
733,582812,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M100 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
734,582813,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M315 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
735,582814,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M308 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
736,582815,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against dye-resistant Streptococcus pneumoniae M55 DR overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
737,582816,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M300 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
738,582817,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M55B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
739,582818,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against dye-resistant Streptococcus pneumoniae M46 DR overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
740,582819,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M46A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
741,582820,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M46B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
742,582821,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae M295 S overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
743,582822,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M303 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
744,582823,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M309 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
745,584114,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli KAM32 harboring Staphylococcus aureus cloned pSP72 lmrS by broth microdilution method,Other,20855745.0,
746,584115,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against Escherichia coli KAM32 harboring pSP72 by broth microdilution method,Other,20855745.0,
747,584116,5,2,,103207558,14710,Unspecified,,,,,Ratio of MIC for Escherichia coli KAM32 harboring cloned pSP72 lmrS to MIC for Escherichia coli KAM32 harboring pSP72,Other,20855745.0,
748,584118,2,3,,103207558,14710,Unspecified,,,,,Inhibition of Staphylococcus aureus LmrS expressed in Escherichia coli KAM32 harboring pSP72 assessed as decrease of ethidium bromide accumulation at 100 uM by fluorescence spectrophotometer relative to control,Other,20855745.0,
749,585481,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
750,585482,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method",Other,20937787.0,
751,585483,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against wild type Streptococcus pneumoniae R6 by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor,Other,20937787.0,
752,585484,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against wild type Streptococcus pneumoniae M4 NCTC 7465 type 1 by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor,Other,20937787.0,
753,585485,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against wild type Streptococcus pneumoniae M3 NCTC 7466 type 2 by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor,Other,20937787.0,
754,585486,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against wild type Streptococcus pneumoniae R6 by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor,Other,20937787.0,
755,585487,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against wild type Streptococcus pneumoniae M3 NCTC 7466 type 2 by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor,Other,20937787.0,
756,585488,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against wild type Streptococcus pneumoniae M4 NCTC 7465 type 1 by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor,Other,20937787.0,
757,585489,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against wild type Streptococcus pneumoniae R6 by standardized agar doubling dilution method,Other,20937787.0,
758,585490,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against wild type Streptococcus pneumoniae M4 NCTC 7465 type 1 by standardized agar doubling dilution method,Other,20937787.0,
759,585491,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against wild type Streptococcus pneumoniae M3 NCTC 7466 type 2 by standardized agar doubling dilution method,Other,20937787.0,
760,585492,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
761,585493,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae by standardized agar doubling dilution method,Other,20937787.0,
762,585494,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor,Other,20937787.0,
763,585495,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor,Other,20937787.0,
764,585496,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method,Other,20937787.0,
765,585681,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor,Other,20937787.0,
766,585682,5,2,,103207558,14710,Unspecified,,,,,Antibacterial activity against dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor,Other,20937787.0,
767,585683,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae by standardized agar doubling dilution method",Other,20937787.0,
768,585684,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
769,585685,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
770,585686,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae R6 by standardized agar doubling dilution method",Other,20937787.0,
771,585687,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M42 overexpressing patA, patB by standardized agar doubling dilution method",Other,20937787.0,
772,585688,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M298 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",Other,20937787.0,
773,585689,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M298 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",Other,20937787.0,
774,585690,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M45 overexpressing patA, patB by standardized agar doubling dilution method",Other,20937787.0,
775,585691,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M45A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",Other,20937787.0,
776,585692,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M45B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",Other,20937787.0,
777,585693,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M50 overexpressing patA, patB by standardized agar doubling dilution method",Other,20937787.0,
778,585694,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M50A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",Other,20937787.0,
779,585695,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M50B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",Other,20937787.0,
780,585696,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M74 overexpressing patA, patB by standardized agar doubling dilution method",Other,20937787.0,
781,585697,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M301 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",Other,20937787.0,
782,585698,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M305 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",Other,20937787.0,
783,585699,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M86 overexpressing patA, patB by standardized agar doubling dilution method",Other,20937787.0,
784,585700,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M86A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",Other,20937787.0,
785,585701,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M86B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",Other,20937787.0,
786,585702,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M87 overexpressing patA, patB by standardized agar doubling dilution method",Other,20937787.0,
787,585703,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M87A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",Other,20937787.0,
788,585704,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M87B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",Other,20937787.0,
789,585705,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M296 overexpressing patA, patB by standardized agar doubling dilution method",Other,20937787.0,
790,585706,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M304 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",Other,20937787.0,
791,585707,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M310 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",Other,20937787.0,
792,585708,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M297 overexpressing patA, patB by standardized agar doubling dilution method",Other,20937787.0,
793,585709,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M311 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",Other,20937787.0,
794,585710,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M311B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",Other,20937787.0,
795,585711,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M79 FQ-R overexpressing patA, patB by standardized agar doubling dilution method",Other,20937787.0,
796,585712,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M316 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",Other,20937787.0,
797,585713,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M317 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",Other,20937787.0,
798,585714,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M83 FQ-R overexpressing patA, patB by standardized agar doubling dilution method",Other,20937787.0,
799,585715,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M318 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",Other,20937787.0,
800,585716,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M319 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",Other,20937787.0,
801,585717,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M97 FQ-R overexpressing patA, patB by standardized agar doubling dilution method",Other,20937787.0,
802,585718,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M302 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",Other,20937787.0,
803,585719,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M306 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",Other,20937787.0,
804,585720,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M98 FQ-R overexpressing patA, patB by standardized agar doubling dilution method",Other,20937787.0,
805,585721,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M314 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",Other,20937787.0,
806,585722,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M307 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",Other,20937787.0,
807,585723,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M100 FQ-R overexpressing patA, patB by standardized agar doubling dilution method",Other,20937787.0,
808,585724,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M315 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",Other,20937787.0,
809,585725,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M308 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",Other,20937787.0,
810,585726,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against dye-resistant Streptococcus pneumoniae M55 DR overexpressing patA, patB by standardized agar doubling dilution method",Other,20937787.0,
811,585727,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M300 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",Other,20937787.0,
812,585728,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M55B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",Other,20937787.0,
813,585729,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against dye-resistant Streptococcus pneumoniae M46 DR overexpressing patA, patB by standardized agar doubling dilution method",Other,20937787.0,
814,585730,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M46A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",Other,20937787.0,
815,585731,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M46B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",Other,20937787.0,
816,585732,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae M295 S overexpressing patA, patB by standardized agar doubling dilution method",Other,20937787.0,
817,585733,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M303 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method",Other,20937787.0,
818,585880,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M309 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method",Other,20937787.0,
819,585881,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae R6 by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
820,585882,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M42 overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
821,585883,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M298 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
822,585884,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M298 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
823,585885,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M45 overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
824,585886,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M45A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
825,585887,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M45B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
826,585888,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M50 overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
827,585889,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M50A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
828,585890,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M50B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
829,585891,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M74 overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
830,585892,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M301 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
831,585893,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M305 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
832,585894,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M86 overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
833,585895,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M86A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
834,585896,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M86B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
835,585897,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M87 overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
836,585898,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M87A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
837,585899,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M87B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
838,585900,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M296 overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
839,585901,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M304 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
840,585902,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M310 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
841,585903,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M297 overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
842,585904,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M311 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
843,585905,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M311B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
844,585906,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M79 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
845,585907,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M316 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
846,585908,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M317 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
847,585909,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M83 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
848,585910,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M318 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
849,585911,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M319 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
850,585912,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M97 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
851,585913,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M302 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
852,585914,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M306 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
853,585915,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M98 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
854,585916,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M314 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
855,585917,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M307 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
856,585918,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M100 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
857,585919,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M315 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
858,585920,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M308 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
859,585921,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against dye-resistant Streptococcus pneumoniae M55 DR overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
860,585922,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M300 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
861,585923,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M55B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
862,586087,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against dye-resistant Streptococcus pneumoniae M46 DR overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
863,586088,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M46A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
864,586089,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M46B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
865,586090,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae M295 S overexpressing patA, patB by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
866,586091,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M303 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
867,586092,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M309 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",Other,20937787.0,
868,586093,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae R6 by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
869,586094,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M42 overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
870,586095,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M298 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
871,586096,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M298 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
872,586097,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M45 overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
873,586098,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M45A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
874,586099,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M45B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
875,586100,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M50 overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
876,586101,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M50A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
877,586102,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M50B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
878,586103,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M74 overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
879,586104,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M301 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
880,586105,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M305 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
881,586106,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M86 overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
882,586107,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M86A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
883,586108,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M86B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
884,586109,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M87 overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
885,586110,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M87A overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
886,586111,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M87B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
887,586112,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M296 overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
888,586113,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M304 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
889,586114,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M310 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
890,586115,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae M297 overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
891,586116,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M311 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
892,586117,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M311B overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
893,586118,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M79 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
894,586119,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M316 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
895,586120,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M317 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
896,586121,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M83 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
897,586122,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M318 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
898,586123,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M319 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
899,586124,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M97 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
900,586125,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M302 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
901,586126,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M306 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
902,586127,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae M98 FQ-R overexpressing patA, patB by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
903,586128,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M314 overexpressing patA, patB and inactivated patA with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
904,586129,5,2,,103207558,14710,Unspecified,,,,,"Antibacterial activity against Streptococcus pneumoniae M307 overexpressing patA, patB and inactivated patB with single mutation by standardized agar doubling dilution method in presence of 50 uM sodium orthovanadate efflux pump inhibitor",Other,20937787.0,
905,588334,1,1,,92764758,14710,Inactive,,,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity,Screening,,
906,588335,1,1,,92764758,14710,Inactive,,,,,Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts,Screening,,
907,588352,1,2,,92764758,14710,Inactive,32307126.0,8202.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3),Screening,,
908,588354,1,1,,92764758,14710,Inactive,22538455.0,8648.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1),Screening,,
909,588358,1,2,,92764758,14710,Inactive,,,,,HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies,Screening,,
910,588391,1,1,,92764758,14710,Inactive,14790033.0,5034.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
911,588405,1,1,,92764758,14710,Active,78486550.0,171071.0,,,HTS Assay for Peg3 Promoter Inhibitors,Screening,,
912,588413,1,2,,92764758,14710,Inactive,6009644.0,14632.0,,,uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay,Screening,,
913,588436,1,1,,92764758,14710,Inactive,,,,,"Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity",Screening,,
914,588453,1,1,,92764758,14710,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
915,588456,1,1,,92764758,14710,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
916,588458,1,1,,92764758,14710,Inactive,4503351.0,1786.0,,,uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay,Screening,,
917,588473,1,1,,92764758,14710,Inactive,30219.0,1393.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
918,588473,1,1,,92764758,14710,Inactive,38349113.0,1395.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
919,588475,1,2,,92764758,14710,Inactive,30219.0,1393.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
920,588475,1,2,,92764758,14710,Inactive,38349113.0,1395.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
921,588489,1,1,,92764758,14710,Active,46367787.0,26986.0,,,uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay,Screening,,
922,588492,1,1,,92764758,14710,Inactive,,,,,uHTS identification of small molecule modulators of myocardial damage,Screening,,
923,588493,1,2,,92764758,14710,Inactive,16306916.0,10213.0,,,uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay,Screening,,
924,588497,1,2,,92764758,14710,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,16604538.0,
925,588497,1,2,,92764758,14710,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20035615.0,
926,588497,1,2,,92764758,14710,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20938917.0,
927,588499,1,3,,92764758,14710,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,16604538.0,
928,588499,1,3,,92764758,14710,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20035615.0,
929,588499,1,3,,92764758,14710,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20938917.0,
930,588501,1,2,,92764758,14710,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,16604538.0,
931,588501,1,2,,92764758,14710,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20035615.0,
932,588501,1,2,,92764758,14710,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20938917.0,
933,588513,1,1,,17389015,14710,Inconclusive,348019627.0,2099.0,19.9526,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
934,588514,1,1,,17389015,14710,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
935,588515,1,1,,17389015,14710,Inconclusive,124375976.0,367.0,1.0,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
936,588516,1,1,,17389015,14710,Inconclusive,124375976.0,367.0,1.0,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
937,588519,1,2,,92124732,14710,Active,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
938,588526,1,1,,17389015,14710,Active,325495553.0,9971.0,15.8489,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
939,588527,1,1,,17389015,14710,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
940,588532,1,1,,17389015,14710,Inconclusive,311348376.0,2908.0,14.1254,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
941,588533,1,1,,17389015,14710,Inconclusive,311348376.0,2908.0,7.0795,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
942,588534,1,1,,17389015,14710,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
943,588535,1,1,,17389015,14710,Active,216409690.0,5467.0,31.6228,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
944,588536,1,1,,17389015,14710,Inconclusive,216409692.0,5468.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
945,588537,1,1,,17389015,14710,Inconclusive,216409692.0,5468.0,44.6684,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
946,588541,1,1,,17389015,14710,Inconclusive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
947,588543,1,1,,17389015,14710,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
948,588544,1,1,,17389015,14710,Inconclusive,325495497.0,6256.0,2.5119,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
949,588545,1,1,,17389015,14710,Inconclusive,189491771.0,7068.0,6.3096,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
950,588546,1,1,,17389015,14710,Active,325495497.0,6256.0,8.9125,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
951,588547,1,1,,17389015,14710,Inconclusive,189491771.0,7068.0,28.1838,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
952,588549,1,1,,92764758,14710,Active,1781172.0,,,,Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
953,588579,1,1,,17389015,14710,Active,7705344.0,51426.0,8.9125,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
954,588579,1,1,,26748838,14710,Active,7705344.0,51426.0,8.9125,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
955,588579,1,1,,92764758,14710,Active,7705344.0,51426.0,19.9526,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
956,588590,1,1,,92764758,14710,Active,154350220.0,11201.0,39.8107,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
957,588591,1,1,,92764758,14710,Active,5729982.0,5429.0,4.4668,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
958,588621,1,1,,92764758,14710,Inactive,90652859.0,84867.0,,,uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay,Screening,,
959,588664,1,2,,92764758,14710,Inactive,62362414.0,25.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
960,588664,1,2,,92764758,14710,Inactive,68989256.0,9610.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
961,588674,1,2,,92764758,14710,Inactive,,,,,Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
962,588689,1,1,,92764758,14710,Inconclusive,219689243.0,,,IC50,Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition,Confirmatory,,
963,588692,2,1,,92764758,14710,Inactive,,,,,Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
964,588726,1,2,,92764758,14710,Inactive,15607504.0,886474.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis,Screening,,
965,588727,1,1,,92764758,14710,Inactive,,,,IC50,"A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83",Confirmatory,,
966,588792,1,1,,92764758,14710,Inactive,32307126.0,8202.0,,,Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3),Screening,,
967,588794,1,1,,92764758,14710,Active,9629429.0,,,,Counterscreen for inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16),Screening,,
968,588795,1,1,,92764758,14710,Active,4758356.0,2237.0,12.5893,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
969,588812,1,1,,17389015,14710,Unspecified,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
970,588812,1,1,1.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
971,588812,1,1,2.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
972,588812,1,1,3.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
973,588812,1,1,4.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
974,588812,1,1,5.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
975,588812,1,1,6.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
976,588812,1,1,7.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
977,588812,1,1,8.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
978,588812,1,1,9.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
979,588812,1,1,10.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
980,588812,1,1,11.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
981,588812,1,1,12.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
982,588812,1,1,13.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
983,588812,1,1,14.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
984,588812,1,1,15.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
985,588812,1,1,16.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
986,588812,1,1,17.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
987,588812,1,1,18.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
988,588812,1,1,19.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
989,588812,1,1,20.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
990,588812,1,1,21.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
991,588812,1,1,22.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
992,588812,1,1,23.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
993,588812,1,1,24.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
994,588812,1,1,25.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
995,588812,1,1,26.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
996,588812,1,1,27.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
997,588812,1,1,28.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
998,588812,1,1,29.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
999,588812,1,1,30.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1000,588812,1,1,31.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1001,588812,1,1,32.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1002,588812,1,1,33.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1003,588812,1,1,34.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1004,588812,1,1,35.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1005,588812,1,1,36.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1006,588812,1,1,37.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1007,588812,1,1,38.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1008,588812,1,1,39.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1009,588812,1,1,40.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1010,588812,1,1,41.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1011,588812,1,1,42.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1012,588812,1,1,43.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1013,588812,1,1,44.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1014,588812,1,1,45.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1015,588812,1,1,46.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1016,588812,1,1,47.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1017,588812,1,1,48.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1018,588812,1,1,49.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1019,588812,1,1,50.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1020,588812,1,1,51.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1021,588812,1,1,52.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1022,588812,1,1,53.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1023,588812,1,1,54.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1024,588812,1,1,55.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1025,588812,1,1,56.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1026,588812,1,1,57.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1027,588812,1,1,58.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1028,588812,1,1,59.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1029,588812,1,1,60.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1030,588812,1,1,61.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1031,588812,1,1,62.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1032,588812,1,1,63.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1033,588812,1,1,64.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1034,588812,1,1,65.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1035,588812,1,1,66.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1036,588812,1,1,67.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1037,588812,1,1,68.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1038,588812,1,1,69.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1039,588812,1,1,70.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1040,588812,1,1,71.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1041,588812,1,1,72.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1042,588812,1,1,73.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1043,588812,1,1,74.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1044,588812,1,1,75.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1045,588812,1,1,76.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1046,588812,1,1,77.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1047,588812,1,1,78.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1048,588812,1,1,79.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1049,588812,1,1,80.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1050,588812,1,1,81.0,17389015,14710,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
1051,588813,1,1,,17389015,14710,Unspecified,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1052,588813,1,1,1.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1053,588813,1,1,2.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1054,588813,1,1,3.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1055,588813,1,1,4.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1056,588813,1,1,5.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1057,588813,1,1,6.0,17389015,14710,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1058,588813,1,1,7.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1059,588813,1,1,8.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1060,588813,1,1,9.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1061,588813,1,1,10.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1062,588813,1,1,11.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1063,588813,1,1,12.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1064,588813,1,1,13.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1065,588813,1,1,14.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1066,588813,1,1,15.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1067,588813,1,1,16.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1068,588813,1,1,17.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1069,588813,1,1,18.0,17389015,14710,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1070,588813,1,1,19.0,17389015,14710,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1071,588813,1,1,20.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1072,588813,1,1,21.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1073,588813,1,1,22.0,17389015,14710,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1074,588813,1,1,23.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1075,588813,1,1,24.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1076,588813,1,1,25.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1077,588813,1,1,26.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1078,588813,1,1,27.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1079,588813,1,1,28.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1080,588813,1,1,29.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1081,588813,1,1,30.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1082,588813,1,1,31.0,17389015,14710,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1083,588813,1,1,32.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1084,588813,1,1,33.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1085,588813,1,1,34.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1086,588813,1,1,35.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1087,588813,1,1,36.0,17389015,14710,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1088,588813,1,1,37.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1089,588813,1,1,38.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1090,588813,1,1,39.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1091,588813,1,1,40.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1092,588813,1,1,41.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1093,588813,1,1,42.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1094,588813,1,1,43.0,17389015,14710,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1095,588813,1,1,44.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1096,588813,1,1,45.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1097,588813,1,1,46.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1098,588813,1,1,47.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1099,588813,1,1,48.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1100,588813,1,1,49.0,17389015,14710,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1101,588813,1,1,50.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1102,588813,1,1,51.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1103,588813,1,1,52.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1104,588813,1,1,53.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1105,588813,1,1,54.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1106,588813,1,1,55.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1107,588813,1,1,56.0,17389015,14710,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1108,588813,1,1,57.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1109,588813,1,1,58.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1110,588813,1,1,59.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1111,588813,1,1,60.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1112,588813,1,1,61.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1113,588813,1,1,62.0,17389015,14710,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1114,588813,1,1,63.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1115,588813,1,1,64.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1116,588813,1,1,65.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1117,588813,1,1,66.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1118,588813,1,1,67.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1119,588813,1,1,68.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1120,588813,1,1,69.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1121,588813,1,1,70.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1122,588813,1,1,71.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1123,588813,1,1,72.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1124,588813,1,1,73.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1125,588813,1,1,74.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1126,588813,1,1,75.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1127,588813,1,1,76.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1128,588813,1,1,77.0,17389015,14710,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1129,588813,1,1,78.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1130,588813,1,1,79.0,17389015,14710,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1131,588813,1,1,80.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1132,588813,1,1,81.0,17389015,14710,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1133,588814,1,3,,92764758,14710,Inactive,37622910.0,1128.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1)",Screening,,
1134,588819,1,4,,92764758,14710,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1).,Screening,,
1135,588820,1,1,,92764758,14710,Inactive,22538455.0,8648.0,,,Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1).,Screening,,
1136,588824,1,1,,92764758,14710,Active,9629429.0,,,,Counterscreen for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16).,Screening,,
1137,588834,2,1,,17389015,14710,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
1138,588834,2,1,,144204674,14710,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
1139,588834,2,1,,144204963,14710,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
1140,588850,1,1,,92764758,14710,Inactive,90421313.0,1080.0,,,uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay,Screening,,
1141,588852,1,3,,92764758,14710,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1),Screening,,
1142,588855,1,1,,92764758,14710,Inconclusive,18418623.0,4088.0,7.0795,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
1143,588856,1,1,,92764758,14710,Inactive,,,,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
1144,594636,6,1,,103207558,14710,Active,,,2.6,IC50,Inhibition of telomerase activity expressed in human SGC7901 cells by SYBER green dye based TRAP,Confirmatory,21486698.0,
1145,602123,1,1,,92764758,14710,Inactive,16128424.0,945085.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon),Screening,,
1146,602141,1,1,,92764758,14710,Inactive,,,,,uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors,Screening,,
1147,602162,1,1,,92764758,14710,Inactive,9955963.0,10058.0,,,Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for MLPCN Compound Set,Screening,,
1148,602163,1,1,,92764758,14710,Active,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA),Screening,,
1149,602179,1,2,,92764758,14710,Inactive,89573979.0,3417.0,,Potency,qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS,Confirmatory,,
1150,602229,1,1,,92764758,14710,Inactive,216409728.0,10002.0,,,"Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3)",Screening,,
1151,602233,1,1,,92764758,14710,Inactive,115503961.0,4357161.0,,Potency,qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
1152,602244,1,2,,92764758,14710,Inactive,5730106.0,10663.0,,,uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay,Screening,,
1153,602247,1,2,,92764758,14710,Inactive,,,,,Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
1154,602248,1,2,,92764758,14710,Inactive,,,,,Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
1155,602250,1,2,,92764758,14710,Inactive,,,,,Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line,Screening,,
1156,602252,1,1,,92764758,14710,Inactive,62868213.0,57120.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1157,602252,1,1,,92764758,14710,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1158,602259,1,1,,92764758,14710,Inactive,46367787.0,26986.0,40.38,IC50_Mean,Dose-response confirmation of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay,Confirmatory,,
1159,602260,1,1,,92764758,14710,Inactive,46367787.0,26986.0,66.0,IC50_Mean,Dose-response secondary confirmation of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay using Cy5 labeled peptide,Confirmatory,,
1160,602261,1,1,,92764758,14710,Inactive,41872631.0,2194.0,,,uHTS identification of small molecule inhibitors of  the thioesterase domain of fatty acid synthase via a fluorescence intensity assay,Screening,,
1161,602270,1,1,,92764758,14710,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical high throughput confirmation assay for activators of Methionine sulfoxide reductase A (MsrA),Screening,,
1162,602274,1,2,,92764758,14710,Inactive,,,,,uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells,Screening,,
1163,602281,1,1,,92764758,14710,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
1164,602281,1,1,,92764758,14710,Inactive,116292172.0,440503.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
1165,602310,1,2,,92764758,14710,Inactive,13399304.0,60489.0,,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
1166,602313,1,1,,92764758,14710,Inactive,22907044.0,200316.0,,Potency,qHTS for Inhibitors of Vif-A3F Interactions: qHTS,Confirmatory,,
1167,602314,1,2,,92124732,14710,Active,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
1168,602332,1,1,,17389015,14710,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1169,602332,1,1,,26748838,14710,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1170,602332,1,1,,92764758,14710,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1171,602346,1,1,,92764758,14710,Inactive,9629361.0,155459.0,,,Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1172,602396,1,2,,92764758,14710,Inactive,4504343.0,2494.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2),Screening,,
1173,602399,1,2,,92764758,14710,Inactive,15927174.0,,,,uHTS identification of inhibitors of NadD in a Colorimetric assay,Screening,,
1174,602410,1,1,,92764758,14710,Inactive,11093520.0,3777.0,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3,Screening,,
1175,602417,1,1,,92764758,14710,Active,78486550.0,171071.0,,,Single concentration confirmation of uHTS hits for Peg3 Promoter Inhibitors via a luciferase reporter assay,Screening,,
1176,602429,1,1,,92764758,14710,Inactive,1762973.0,7341.0,,,uHTS identification of SUMO1-mediated protein-protein interactions,Screening,,
1177,602438,1,1,,92764758,14710,Active,160877737.0,,,,uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay,Screening,,
1178,602440,1,1,,92764758,14710,Active,262118306.0,123228.0,,,uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8),Screening,,
1179,602449,1,2,,92764758,14710,Inactive,,,,,uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay,Screening,,
1180,615635,3,2,,103207558,14710,Unspecified,,,,,Displacement of methyl green dye from DNA after 24 hrs by spectrophotometric analysis,Other,21705114.0,
1181,623870,1,1,,92764758,14710,Inactive,2702319.0,405.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1182,623870,1,1,,92764758,14710,Inactive,5454102.0,10460.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1183,623877,1,1,,92764758,14710,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that activate/potentiate calcium-activated chloride channels (TMEM16A),Screening,,
1184,624030,1,2,,17389015,14710,Inactive,160794.0,,,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
1185,624030,1,2,,26748838,14710,Inactive,160794.0,,,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
1186,624031,1,2,,17389015,14710,Inactive,,,,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
1187,624031,1,2,,26748838,14710,Inactive,,,,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
1188,624032,1,2,,17389015,14710,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
1189,624032,1,2,,26748838,14710,Inconclusive,8393992.0,24660.0,14.3818,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
1190,624037,1,3,,92764758,14710,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
1191,624038,1,3,,92764758,14710,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
1192,624040,1,3,,92764758,14710,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
1193,624044,1,2,,17389015,14710,Inconclusive,8393992.0,24660.0,1.1212,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
1194,624044,1,2,,26748838,14710,Inconclusive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
1195,624125,1,4,,92764758,14710,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
1196,624126,1,3,,92764758,14710,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
1197,624127,1,2,,92764758,14710,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
1198,624167,1,1,,92764758,14710,Active,78486550.0,171071.0,15.7,IC50_PEG-3_Mean,Dose Response confirmation of uHTS small molecule Peg3 Promoter Inhibitor hits in a screening assay,Confirmatory,,
1199,624167,1,1,4.0,92764758,14710,Active,78486550.0,171071.0,,IC50_PEG-3_Mean,Dose Response confirmation of uHTS small molecule Peg3 Promoter Inhibitor hits in a screening assay,Confirmatory,,
1200,624167,1,1,5.0,92764758,14710,Unspecified,78486550.0,171071.0,,IC50_PEG-3_Mean,Dose Response confirmation of uHTS small molecule Peg3 Promoter Inhibitor hits in a screening assay,Confirmatory,,
1201,624167,1,1,6.0,92764758,14710,Unspecified,78486550.0,171071.0,,IC50_PEG-3_Mean,Dose Response confirmation of uHTS small molecule Peg3 Promoter Inhibitor hits in a screening assay,Confirmatory,,
1202,624168,1,1,,92764758,14710,Inactive,47678551.0,9215.0,,,uHTS identification of small molecule activators of alpha dystroglycan glycosylation,Screening,,
1203,624169,1,1,,92764758,14710,Inactive,27753985.0,15558.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A),Screening,,
1204,624170,1,1,,17389015,14710,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
1205,624170,1,1,,26748838,14710,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
1206,624170,1,1,,92764758,14710,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
1207,624171,1,1,,92764758,14710,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators,Confirmatory,,
1208,624172,1,1,,17389015,14710,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
1209,624172,1,1,,26748838,14710,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
1210,624172,1,1,,92764758,14710,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
1211,624173,1,3,,17389015,14710,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
1212,624173,1,3,,26748838,14710,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
1213,624173,1,3,,92764758,14710,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
1214,624178,1,1,,92764758,14710,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
1215,624202,1,1,,92764758,14710,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
1216,624204,1,2,,92764758,14710,Inactive,7657550.0,,,,"uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay",Screening,,
1217,624246,1,1,,92764758,14710,Active,343478176.0,2078.0,15.8489,Potency,qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction,Confirmatory,,
1218,624256,1,2,,92764758,14710,Active,,3205.0,,,HTS to identify compounds that promote myeloid differentiation with MLPCN compound set,Screening,,
1219,624263,1,1,,26748838,14710,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1220,624263,1,1,,26748838,14710,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1221,624263,1,1,,92764758,14710,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1222,624263,1,1,,92764758,14710,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1223,624267,1,2,,92764758,14710,Inactive,4506537.0,8767.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
1224,624267,1,2,,92764758,14710,Inactive,119603173.0,64127.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
1225,624268,1,3,,92764758,14710,Inactive,71746704.0,3662741.0,,,Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS),Screening,,
1226,624273,1,1,,92764758,14710,Active,1781172.0,,27.44,AC50_uM,Fluorescence polarization aasay to screen for inhibitors that compete for the binding of FadD28 to a bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
1227,624287,1,1,,92764758,14710,Inactive,52000961.0,2778.0,,Potency,"qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS",Confirmatory,,
1228,624288,1,1,,92764758,14710,Inconclusive,52000961.0,2778.0,35.4813,Potency,"qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS",Confirmatory,,
1229,624291,1,1,,92764758,14710,Inactive,121312.0,1081.0,,Potency,qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy,Confirmatory,,
1230,624296,1,1,,17389015,14710,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
1231,624296,1,1,,26748838,14710,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
1232,624296,1,1,,92764758,14710,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
1233,624297,1,1,,17389015,14710,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
1234,624297,1,1,,26748838,14710,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
1235,624297,1,1,,92764758,14710,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
1236,624304,1,2,,92764758,14710,Inactive,25148072.0,177343.0,,,uHTS identification of SKN-1 Inhibitors in a fluoresence assay,Screening,,
1237,624330,1,2,,92764758,14710,Inactive,21361397.0,29127.0,,IC50,Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP -  Primary and Confirmatory Screens,Confirmatory,,
1238,624349,1,2,,92124732,14710,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
1239,624352,1,1,,92764758,14710,Inactive,40254439.0,2034.0,,,uHTS identification of HIF-2a Inhibitors in a luminesence assay,Screening,,
1240,624354,1,1,,92764758,14710,Inactive,224494019.0,8795.0,,,uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay,Screening,,
1241,624377,1,1,,92764758,14710,Inactive,351542238.0,50807.0,,,"Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1)",Screening,,
1242,624414,1,1,,92764758,14710,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
1243,624415,1,2,,92764758,14710,Inactive,10092597.0,57192.0,,,qHTS for Inhibitors of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
1244,624416,1,1,,92764758,14710,Inactive,9629363.0,155971.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9",Screening,,
1245,624417,1,1,,92764758,14710,Active,1724069.0,2740.0,5.6234,Potency,qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode),Confirmatory,,
1246,624418,1,1,,92764758,14710,Inconclusive,,,8.9125,Potency,qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen,Confirmatory,,
1247,624463,1,1,,92764758,14710,Active,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists,Other,,
1248,624464,1,1,,92764758,14710,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators,Other,,
1249,624465,1,1,,92764758,14710,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists,Other,,
1250,624466,1,3,,92764758,14710,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
1251,624467,1,1,,92764758,14710,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
1252,624483,1,1,,92764758,14710,Inactive,,,,,Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease,Screening,,
1253,639393,1,4,,103207558,14710,Unspecified,,,,,Binding affinity to calf thymus DNA assessed as binding constant at pH 7 by fluorescence quenching assay,Other,21964184.0,
1254,639399,1,4,,103207558,14710,Active,,,,,Binding affinity to calf thymus DNA assessed as intercalation measuring viscosity index at compound to DNA molar ratio of 0.2 at pH 7 by viscometry method,Other,21964184.0,
1255,644952,3,2,,103207558,14710,Active,,,5.0,Kd,Binding affinity to human pre-hsa-mir-155 miRNA assessed as increase in fluorescence after 30 mins by fluorimetry,Confirmatory,22257890.0,
1256,651550,1,1,,92764758,14710,Inactive,60391226.0,207.0,,,HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen,Screening,,
1257,651560,1,1,,92764758,14710,Active,1709543.0,52.0,,,"uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay",Screening,,
1258,651572,1,2,,92764758,14710,Inactive,21489979.0,246310.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1),Screening,,
1259,651582,1,1,,92764758,14710,Inactive,,,,,uHTS identification of small molecule Triacylglycerol inhbitors in a fluoresence assay,Screening,,
1260,651602,1,1,,92764758,14710,Inactive,16130723.0,947287.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
1261,651602,1,1,,92764758,14710,Inactive,16130724.0,947286.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
1262,651602,1,1,,92764758,14710,Inactive,16130726.0,947294.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
1263,651610,2,1,,92764758,14710,Inactive,,,,,HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1264,651611,1,1,,92764758,14710,Active,,,,,Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify nonselective inhibitors of the Steroidogenic acute regulatory protein (StAR) promoter or luminescence assay artifacts,Screening,,
1265,651613,1,1,,92764758,14710,Active,4504343.0,2494.0,,,Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2),Screening,,
1266,651614,1,1,,92764758,14710,Active,20070193.0,2516.0,,,Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1),Screening,,
1267,651615,1,1,,92764758,14710,Active,9629429.0,,,,Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16),Screening,,
1268,651631,4,1,,144204674,14710,Active,269849759.0,7157.0,3.3491,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
1269,651631,4,1,,144204963,14710,Active,269849759.0,7157.0,10.5909,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
1270,651631,4,1,,144209709,14710,Active,269849759.0,7157.0,2.158,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
1271,651632,4,1,,144204674,14710,Inactive,296439460.0,79915.0,13.3332,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
1272,651632,4,1,,144204963,14710,Inactive,296439460.0,79915.0,33.4915,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
1273,651632,4,1,,144209709,14710,Inactive,296439460.0,79915.0,13.6159,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
1274,651633,4,1,,144204674,14710,Active,,,9.4392,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
1275,651633,4,1,,144204963,14710,Inconclusive,,,33.4915,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
1276,651633,4,1,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
1277,651634,4,1,,144204674,14710,Active,,,23.7101,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
1278,651634,4,1,,144204963,14710,Inconclusive,,,29.8493,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
1279,651634,4,1,,144209709,14710,Active,,,54.2058,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
1280,651635,1,3,,92764758,14710,Inconclusive,171543895.0,6311.0,42.2841,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
1281,651636,1,1,,92764758,14710,Inactive,4826706.0,1880.0,,,uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay,Screening,,
1282,651640,1,1,,92764758,14710,Inactive,,,,,DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity,Screening,,
1283,651644,1,1,,92764758,14710,Inconclusive,28872817.0,155807.0,3.9811,Potency,qHTS Assay for Inhibitors of the HIV-1 protein Vpr,Confirmatory,,
1284,651647,1,1,,92764758,14710,Inactive,4826834.0,4323.0,,,uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay,Screening,,
1285,651658,1,1,,92764758,14710,Inactive,10190672.0,27006.0,,,Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1286,651661,2,1,,92764758,14710,Inactive,,,,,Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1287,651699,1,1,,92764758,14710,Inactive,4502169.0,8883.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
1288,651699,1,1,,92764758,14710,Inactive,4507791.0,9040.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
1289,651702,1,2,,92764758,14710,Inactive,,,,,Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library,Screening,,
1290,651704,2,1,,92764758,14710,Active,156104889.0,4300.0,,,Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1291,651710,1,1,,92764758,14710,Inactive,109637798.0,5893.0,,,FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1292,651711,2,1,,92764758,14710,Inactive,2501205.0,10130.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of ERp5 Measured in Biochemical System Using Plate Reader - 7002-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1293,651718,1,2,,92764758,14710,Active,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA),Screening,,
1294,651719,1,2,,92764758,14710,Inactive,4503907.0,8484.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3),Screening,,
1295,651724,1,1,,92764758,14710,Inactive,1730321.0,5932.0,,,qHTS Assay for Inhibitors of the CtBP/E1A Interaction,Screening,,
1296,651725,1,1,,92764758,14710,Inconclusive,1246761.0,6495.0,,,qHTS Assay for Inhibitors of the Six1/Eya2 Interaction,Screening,,
1297,651741,1,1,,17389015,14710,Active,20149576.0,4780.0,33.4915,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1298,651743,1,1,,17389015,14710,Active,269849759.0,7157.0,8.9125,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
1299,651749,1,1,,17389015,14710,Inconclusive,34577122.0,4790.0,22.3872,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
1300,651751,1,1,,17389015,14710,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
1301,651754,1,1,,17389015,14710,Inconclusive,,,23.7101,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay,Confirmatory,,
1302,651755,1,1,,17389015,14710,Active,,,11.8832,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay,Confirmatory,,
1303,651757,1,1,,17389015,14710,Active,25952111.0,7124.0,37.578,Potency,qHTS assay to identify small molecules that stimulate Tumor Necrosis Factor-alpha (TNF-alpha) secretion,Confirmatory,,
1304,651758,1,1,,17389015,14710,Inconclusive,186368.0,3576.0,,Potency,qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion,Confirmatory,,
1305,651768,1,2,,92764758,14710,Active,3719421.0,7486.0,2.9935,Potency,qHTS for Inhibitors of WRN Helicase,Confirmatory,,
1306,651777,1,1,,17389015,14710,Inactive,51095037.0,196.0,,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
1307,651778,1,1,,17389015,14710,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
1308,651800,1,1,,92764758,14710,Active,2358024.0,6955.0,,,Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe,Screening,,
1309,651802,1,1,,17389015,14710,Inactive,49066040.0,6097.0,,Potency,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
1310,651819,1,1,,92764758,14710,Inactive,83758679.0,153562.0,,,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity,Screening,,
1311,651820,1,1,,92764758,14710,Inconclusive,,,3.9811,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
1312,651821,2,4,,92764758,14710,Inactive,,,,,Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats,Screening,,
1313,651822,1,1,,92764758,14710,Active,73586699.0,281312.0,,,Absorbance-based biochemical high throughput confirmation assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA),Screening,,
1314,651838,1,1,,17389015,14710,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1315,651838,1,1,1.0,17389015,14710,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1316,651838,1,1,2.0,17389015,14710,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1317,651838,1,1,3.0,17389015,14710,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1318,651838,1,1,4.0,17389015,14710,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1319,651838,1,1,5.0,17389015,14710,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1320,651838,1,1,6.0,17389015,14710,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1321,651838,1,1,7.0,17389015,14710,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1322,651838,1,1,8.0,17389015,14710,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1323,651957,1,1,,92764758,14710,Inactive,5729858.0,10499.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2),Screening,,
1324,651958,1,1,,92764758,14710,Active,76364066.0,2943075.0,,,Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate,Screening,,
1325,651965,1,1,,92764758,14710,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
1326,651999,1,1,,92764758,14710,Inactive,38027923.0,10987.0,,,"uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay",Screening,,
1327,652010,1,1,,92764758,14710,Inactive,5016090.0,190.0,,,"Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1",Screening,,
1328,652017,1,1,,92764758,14710,Inactive,119579215.0,6595.0,,,"Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM)",Screening,,
1329,652025,1,1,,92764758,14710,Inactive,7110653.0,16183.0,,Potency,qHTS of IL-2 Activators,Confirmatory,,
1330,652035,1,1,,92764758,14710,Active,30794280.0,280717.0,,,Fluorescence-based biochemical high throughput counterscreen assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled BSA probe,Screening,,
1331,652036,1,1,,92764758,14710,Active,2358024.0,6955.0,,,Fluorescence-based biochemical primary high throughput confirmation assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe,Screening,,
1332,652039,1,1,,92764758,14710,Inactive,21327705.0,5650.0,,,Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen,Screening,,
1333,652048,1,2,,92764758,14710,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
1334,652048,1,2,,144204674,14710,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
1335,652048,1,2,,144204963,14710,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
1336,652051,1,1,,92764758,14710,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
1337,652051,1,1,,144204674,14710,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
1338,652051,1,1,,144204963,14710,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
1339,652054,1,1,,92764758,14710,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Antagonist: qHTS,Screening,,
1340,652067,1,4,,92764758,14710,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12),Screening,,
1341,652104,1,1,,92764758,14710,Inactive,20140568.0,23435.0,,Potency,qHTS of TDP-43 Inhibitors,Confirmatory,,
1342,652105,1,1,,92764758,14710,Inactive,18266879.0,5305.0,,Potency,qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K),Confirmatory,,
1343,652106,1,1,,92764758,14710,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
1344,652115,1,1,,92764758,14710,Inactive,38258652.0,23408.0,,,MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5,Screening,,
1345,652126,1,3,,92764758,14710,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12),Screening,,
1346,652154,1,1,,92764758,14710,Active,998701.0,7849.0,,,HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1347,652162,2,1,,92764758,14710,Inactive,126698238.0,4914074.0,,,C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1348,652163,1,1,,92764758,14710,Active,47496637.0,6275.0,,,S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1349,652197,1,1,,92764758,14710,Inactive,21315078.0,51752.0,,,MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1350,652257,1,1,,92764758,14710,Active,32425330.0,3276.0,,,Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1),Screening,,
1351,653484,4,5,,103207558,14710,Active,6226780.0,7015.0,2.47,IC50,Inhibition of telomerase supercoiling activity in human MGC803 cells after 24 hrs by TRAP-PCR-ELISA assay,Confirmatory,22405648.0,
1352,660264,1,3,,103207558,14710,Unspecified,,,,,Ratio of MIC for wild type Escherichia coli HS414 to MIC for acrB-deficient Escherichia coli HS832 by agar dilution method,Other,22483632.0,
1353,660265,2,2,,103207558,14710,Unspecified,,,,,Antimicrobial activity against wild type Escherichia coli expressing AcrAB-TolC efflux pump,Other,22483632.0,
1354,678964,1,8,,103207558,14710,Unspecified,67462103.0,9429.0,,,TP_TRANSPORTER: uptake in BCRP-expressing Lactococcus lactis cells,Other,12668685.0,
1355,681211,1,8,,103207558,14710,Unspecified,67462103.0,9429.0,,,TP_TRANSPORTER: growth inhibition in BCRP-expressing Lactococcus lactis cells,Other,12668685.0,
1356,686940,1,1,,92764758,14710,Inactive,14149746.0,7026.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2),Screening,,
1357,686964,1,1,,92764758,14710,Active,21595776.0,8932.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide,Screening,,
1358,686970,1,2,,92764758,14710,Inconclusive,49168486.0,3417.0,14.581,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line,Confirmatory,,
1359,686971,1,2,,92764758,14710,Active,,,16.3601,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line,Confirmatory,,
1360,686976,1,1,,92764758,14710,Active,76364066.0,2943075.0,,,Fluorescence-based biochemical high throughput screening confirmation assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate,Screening,,
1361,686978,1,1,,92764758,14710,Active,79154014.0,55775.0,0.1458,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1362,686978,1,1,,144204674,14710,Active,79154014.0,55775.0,0.2661,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1363,686978,1,1,,144204963,14710,Active,79154014.0,55775.0,0.3264,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1364,686979,1,1,,92764758,14710,Active,79154014.0,55775.0,0.1636,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1365,686979,1,1,,144204674,14710,Active,79154014.0,55775.0,0.2371,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1366,686979,1,1,,144204963,14710,Active,79154014.0,55775.0,0.5174,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1367,686992,2,1,,92764758,14710,Inactive,187960042.0,6401.0,,,Identification of agents that induce E-selectin on human endothelial cells Measured in Cell-Based System Using Imaging - 2152-01_Activator_SinglePoint_HTS_Activity,Screening,,
1368,686996,1,1,,92764758,14710,Active,13325293.0,839.0,,,VEID(2) R110 Enzymatic Primary HTS to identify Inhibitors of Caspase 6 Measured in Biochemical System Using Plate Reader - 7052-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1369,687014,1,1,,92764758,14710,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the DAF-12 from the parasite H. glycines (hgDAF-12).,Screening,,
1370,687016,1,1,,92764758,14710,Active,115430235.0,29128.0,,,Counterscreen for inhibitors of 5-meCpG-binding domain protein 2 (MBD2): TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of binding of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) to methylated oligonucleotide,Screening,,
1371,687036,1,1,,92764758,14710,Inactive,32425330.0,3276.0,,,Fluorescence polarization-based biochemical high throughput confirmation assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1),Screening,,
1372,695925,2,2,,103207558,14710,Active,,,2.0,IC50,Inhibition of HIV-1 reverse transcriptase using Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,Confirmatory,22695131.0,
1373,702826,1,2,,103207558,14710,Active,,,,,Induction of DNA intercalation in Escherichia coli pBR322 DNA assessed as induction of supercoiled DNA at 1 ug/ml incubated for 15 mins by electrophoresis based Top1 unwinding assay,Other,22867019.0,
1374,720496,1,1,,92764758,14710,Active,154350220.0,11201.0,15.003,Potency,qHTS for Inhibitors of Polymerase Iota: Confirmatory Assay for Cherry-picked Compounds,Confirmatory,,
1375,720498,1,2,,92764758,14710,Active,4758356.0,2237.0,16.9441,Potency,qHTS Assay for the Inhibitors of FEN1: Confirmatory Assay for Cherry-picked Compounds,Confirmatory,,
1376,720501,1,1,,92764758,14710,Active,7705344.0,51426.0,9.4662,Potency,qHTS for Inhibitors of Polymerase Kappa: Confirmatory Assay for Cherry-picked Compounds,Confirmatory,23056190.0,
1377,720502,1,1,,92764758,14710,Inconclusive,5729982.0,5429.0,60.1198,Potency,qHTS for Inhibitors of Polymerase Eta: Confirmatory Assay for Cherry-picked Compounds,Confirmatory,,
1378,720504,1,1,,92764758,14710,Inactive,21359873.0,5347.0,,Potency,qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen,Confirmatory,,
1379,720508,1,1,,92764758,14710,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn7) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
1380,720509,1,1,,92764758,14710,Active,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn6) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
1381,720511,1,1,,92764758,14710,Active,89348172.0,1080.0,,,Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_SinglePoint_HTS_Activity,Screening,,
1382,720516,2,1,,144204674,14710,Inconclusive,296439460.0,79915.0,14.3968,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
1383,720516,2,1,,144204963,14710,Inconclusive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
1384,720516,2,1,,144209709,14710,Inconclusive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
1385,720530,1,1,,92764758,14710,Active,115430235.0,29128.0,,,Counterscreen for inhibitors of 5-meCpG-binding domain protein 2 (MBD2): TRFRET-based biochemical high throughput screening assay to identify inhibitors of binding of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) to methylated oligonucleotide,Screening,,
1386,720531,1,1,,92764758,14710,Active,21595776.0,8932.0,,,TRFRET-based biochemical high throughput confirmation assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide,Screening,,
1387,720532,1,1,,144204674,14710,Inconclusive,420597.0,,2.5119,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1388,720532,1,1,,144204963,14710,Inconclusive,420597.0,,25.1189,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1389,720533,1,1,,144204674,14710,Inconclusive,,,35.4813,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1390,720533,1,1,,144204963,14710,Inconclusive,,,35.4813,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1391,720542,1,2,,92764758,14710,Inactive,23496270.0,810891.0,,Potency,qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen,Confirmatory,,
1392,720543,1,1,,92764758,14710,Active,326937491.0,105501.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of alpha/beta hydrolase domain containing 4 (ABHD4).,Screening,,
1393,720551,1,2,,92764758,14710,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Wildtype qHTS,Confirmatory,,
1394,720552,2,1,,144204674,14710,Active,269849759.0,7157.0,4.59657,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
1395,720552,2,1,,144204963,14710,Active,269849759.0,7157.0,10.9002,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
1396,720552,2,1,,144209709,14710,Active,269849759.0,7157.0,2.2423900000000003,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
1397,720553,1,2,,92764758,14710,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Mutant qHTS,Confirmatory,,
1398,720577,1,1,,92764758,14710,Active,76364066.0,2943075.0,3.321,IC50,Counterscreen for inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate: Fluorescence-based biochemical high throughput screening assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Ub-AMC substrate,Confirmatory,,
1399,720578,1,1,,92764758,14710,Active,76364066.0,2943075.0,1.558,IC50,Fluorescence-based biochemical high throughput screening dose response assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate,Confirmatory,,
1400,720579,2,1,,92764758,14710,Inactive,222762.0,3707576.0,14.1254,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
1401,720579,2,1,,144204963,14710,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
1402,720580,1,1,,92764758,14710,Inactive,222762.0,3707576.0,10.0,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
1403,720580,1,1,,144204963,14710,Inactive,222762.0,3707576.0,10.0,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
1404,720582,1,1,,92764758,14710,Inactive,2393947.0,102.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM10.,Screening,,
1405,720596,1,1,,92764758,14710,Inactive,4506113.0,5621.0,,,TRFRET-based cell-based primary high throughput screening assay to identify inhibitors of cell surface Prion Protein (PRPC),Screening,,
1406,720634,2,1,,144204674,14710,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
1407,720634,2,1,,144204963,14710,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
1408,720634,2,1,,144209709,14710,Inactive,,,2.7167,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
1409,720635,2,1,,144204674,14710,Inconclusive,,,1.496,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
1410,720635,2,1,,144204963,14710,Active,,,2.2095,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
1411,720635,2,1,,144209709,14710,Inconclusive,,,0.0431,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
1412,720636,1,1,,17389015,14710,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
1413,720637,2,1,,144204674,14710,Inconclusive,,,92.6025,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
1414,720637,2,1,,144204963,14710,Inconclusive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
1415,720637,2,1,,144209709,14710,Active,,,10.8155,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
1416,720647,1,2,,92764758,14710,Inactive,,,,,Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfected HEK293 cells Inhibition,Screening,,
1417,720648,1,1,,92764758,14710,Inactive,73747889.0,6868.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM17.,Screening,,
1418,720652,1,1,,17389015,14710,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1419,720653,1,1,,17389015,14710,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
1420,720658,1,1,,92764758,14710,Active,326937491.0,105501.0,,,Fluorescence polarization-based biochemical high throughput confirmation assay to identify inhibitors of alpha/beta hydrolase domain containing 4 (ABHD4).,Screening,,
1421,720659,1,1,,17389015,14710,Inactive,325495557.0,8856.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
1422,720674,2,2,,144204674,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
1423,720674,2,2,,144204963,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
1424,720674,2,2,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
1425,720675,2,2,,144204674,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
1426,720675,2,2,,144204963,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
1427,720675,2,2,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
1428,720678,2,1,,144204674,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
1429,720678,2,1,,144204963,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
1430,720678,2,1,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
1431,720679,2,1,,144204674,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
1432,720679,2,1,,144204963,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
1433,720679,2,1,,144209709,14710,Inconclusive,,,44.6684,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
1434,720680,2,1,,144204674,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
1435,720680,2,1,,144204963,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
1436,720680,2,1,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
1437,720681,2,1,,144204674,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
1438,720681,2,1,,144204963,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
1439,720681,2,1,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
1440,720682,2,1,,144204674,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
1441,720682,2,1,,144204963,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
1442,720682,2,1,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
1443,720683,2,1,,144204674,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
1444,720683,2,1,,144204963,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
1445,720683,2,1,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
1446,720684,2,1,,144204674,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
1447,720684,2,1,,144204963,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
1448,720684,2,1,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
1449,720685,2,1,,144204674,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
1450,720685,2,1,,144204963,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
1451,720685,2,1,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
1452,720686,2,1,,144204674,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
1453,720686,2,1,,144204963,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
1454,720686,2,1,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
1455,720687,2,2,,144204674,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
1456,720687,2,2,,144204963,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
1457,720687,2,2,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
1458,720691,4,1,,144204674,14710,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1459,720691,4,1,,144204963,14710,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1460,720691,4,1,,144209709,14710,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1461,720692,3,1,,144204674,14710,Inconclusive,311348376.0,2908.0,1.8996,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1462,720692,3,1,,144204963,14710,Inconclusive,311348376.0,2908.0,2.6832,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1463,720692,3,1,,144209709,14710,Inconclusive,311348376.0,2908.0,1.7297,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1464,720693,3,1,,144204674,14710,Active,,,16.9301,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
1465,720693,3,1,,144204963,14710,Active,,,18.9959,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
1466,720693,3,1,,144209709,14710,Active,,,13.7398,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
1467,720700,1,4,,92764758,14710,Inactive,223459640.0,5335.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-gamma1).,Screening,,
1468,720702,1,1,,92764758,14710,Active,23510348.0,51567.0,,,Epi Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of human tyrosyl-DNA phosphodiesterase 2 (TDP2),Screening,,
1469,720704,1,4,,92764758,14710,Inactive,148745659.0,5331.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-beta3).,Screening,,
1470,720706,1,2,,92764758,14710,Inactive,,,,,HTS for Bacterial rRNA inhibitors Measured in Microorganism-Based System Using Plate Reader - 7056-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1471,720707,1,2,,92764758,14710,Inactive,317373593.0,10411.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
1472,720708,1,2,,92764758,14710,Inactive,32171491.0,11069.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen,Confirmatory,,
1473,720709,1,2,,92764758,14710,Inactive,317373593.0,10411.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
1474,720711,1,2,,92764758,14710,Inactive,32171491.0,11069.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen,Confirmatory,,
1475,720717,1,3,,92124732,14710,Active,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
1476,720719,2,1,,144204674,14710,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1477,720719,2,1,,144204963,14710,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1478,720719,2,1,,144209709,14710,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1479,720725,2,1,,144204674,14710,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1480,720725,2,1,,144204963,14710,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1481,720725,2,1,,144209709,14710,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1482,725721,2,5,,103207558,14710,Active,6226780.0,7015.0,2.39,IC50,Inhibition of telomerase-mediated supercoiling activity in human MGC803 cells after 24 hrs by TRAP-PCR-ELISA assay,Confirmatory,23265905.0,
1483,735444,4,2,,103207558,14710,Active,6226780.0,7015.0,2.6,IC50,Inhibition of telomerase in human SGC7901 cells by TRAP assay,Confirmatory,23312949.0,
1484,736816,1,3,,103207558,14710,Active,,,,,Induction of DNA intercalation in negatively Escherichia coli super coiled small circular plasmid DNA assessed as retradation of DNA migration at 100 uM incubated for 20 mins at 37 degC by agarose-gel electrophoresis,Other,23321564.0,
1485,743012,3,1,,144204674,14710,Active,,,0.2113,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
1486,743012,3,1,,144204963,14710,Active,,,0.5308,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
1487,743012,3,1,,144209709,14710,Active,,,0.1714,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
1488,743014,3,1,,144204674,14710,Active,,,0.3758,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
1489,743014,3,1,,144204963,14710,Active,,,0.8413,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
1490,743014,3,1,,144209709,14710,Active,,,0.0964,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
1491,743015,3,1,,144204674,14710,Active,,,0.2985,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
1492,743015,3,1,,144204963,14710,Active,,,0.7498,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
1493,743015,3,1,,144209709,14710,Active,,,0.0859,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
1494,743033,3,1,,144204674,14710,Inconclusive,,,18.9959,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
1495,743033,3,1,,144204963,14710,Active,,,11.9856,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
1496,743033,3,1,,144209709,14710,Active,,,4.8751,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
1497,743035,2,1,,144204674,14710,Active,124375976.0,367.0,26.8325,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1498,743035,2,1,,144204963,14710,Inconclusive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1499,743035,2,1,,144209709,14710,Active,124375976.0,367.0,17.2974,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1500,743036,2,1,,144204674,14710,Active,124375976.0,367.0,3.378,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1501,743036,2,1,,144204963,14710,Active,124375976.0,367.0,8.4852,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1502,743036,2,1,,144209709,14710,Active,124375976.0,367.0,2.7414,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1503,743040,3,1,,144204674,14710,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1504,743040,3,1,,144204963,14710,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1505,743040,3,1,,144209709,14710,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1506,743041,3,1,,144204674,14710,Active,,,13.3332,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
1507,743041,3,1,,144204963,14710,Active,,,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
1508,743041,3,1,,144209709,14710,Active,,,30.4821,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
1509,743042,3,1,,144204674,14710,Active,124375976.0,367.0,21.1317,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1510,743042,3,1,,144204963,14710,Inconclusive,124375976.0,367.0,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1511,743042,3,1,,144209709,14710,Active,124375976.0,367.0,15.2773,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1512,743053,2,1,,144204674,14710,Active,124375976.0,367.0,2.78822,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1513,743053,2,1,,144204963,14710,Active,124375976.0,367.0,7.5624199999999995,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1514,743053,2,1,,144209709,14710,Active,124375976.0,367.0,2.17761,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1515,743054,2,1,,144204674,14710,Inconclusive,124375976.0,367.0,20.3361,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
1516,743054,2,1,,144204963,14710,Inconclusive,124375976.0,367.0,26.6032,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
1517,743054,2,1,,144209709,14710,Inconclusive,124375976.0,367.0,10.4083,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
1518,743063,2,1,,144204674,14710,Inconclusive,124375976.0,367.0,23.9145,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1519,743063,2,1,,144204963,14710,Inconclusive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1520,743063,2,1,,144209709,14710,Inconclusive,124375976.0,367.0,16.0194,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1521,743064,3,1,,144204674,14710,Inconclusive,,,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1522,743064,3,1,,144204963,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1523,743064,3,1,,144209709,14710,Active,,,54.2058,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1524,743065,3,1,,144204674,14710,Active,399498506.0,24831.0,23.7101,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1525,743065,3,1,,144204963,14710,Inconclusive,399498506.0,24831.0,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1526,743065,3,1,,144209709,14710,Active,399498506.0,24831.0,27.1672,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1527,743066,3,1,,144204674,14710,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1528,743066,3,1,,144204963,14710,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1529,743066,3,1,,144209709,14710,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1530,743067,2,1,,144204674,14710,Inconclusive,399498506.0,24831.0,21.1317,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1531,743067,2,1,,144204963,14710,Active,399498506.0,24831.0,28.1796,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1532,743067,2,1,,144209709,14710,Inconclusive,399498506.0,24831.0,24.2128,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1533,743069,2,1,,144204674,14710,Active,348019627.0,2099.0,26.8325,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1534,743069,2,1,,144204963,14710,Inconclusive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1535,743069,2,1,,144209709,14710,Active,348019627.0,2099.0,30.7596,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1536,743074,2,1,,144204674,14710,Inconclusive,,,26.8325,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1537,743074,2,1,,144204963,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1538,743074,2,1,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1539,743075,2,1,,144204674,14710,Active,348019627.0,2099.0,4.2527,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1540,743075,2,1,,144204963,14710,Active,348019627.0,2099.0,18.9959,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1541,743075,2,1,,144209709,14710,Active,348019627.0,2099.0,5.4699,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1542,743077,2,1,,144204674,14710,Active,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1543,743077,2,1,,144204963,14710,Active,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1544,743077,2,1,,144209709,14710,Active,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1545,743078,2,1,,144204674,14710,Active,348019627.0,2099.0,23.9145,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1546,743078,2,1,,144204963,14710,Inconclusive,348019627.0,2099.0,3.79019,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1547,743078,2,1,,144209709,14710,Active,348019627.0,2099.0,34.5128,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1548,743079,3,1,,144204674,14710,Inconclusive,348019627.0,2099.0,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1549,743079,3,1,,144204963,14710,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1550,743079,3,1,,144209709,14710,Inconclusive,348019627.0,2099.0,27.1672,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1551,743080,3,1,,144204674,14710,Inconclusive,348019627.0,2099.0,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1552,743080,3,1,,144204963,14710,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1553,743080,3,1,,144209709,14710,Inconclusive,348019627.0,2099.0,60.8199,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1554,743081,3,1,,144204674,14710,Inconclusive,,,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1555,743081,3,1,,144204963,14710,Inconclusive,,,23.7101,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1556,743081,3,1,,144209709,14710,Active,,,54.2058,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1557,743083,3,1,,144204674,14710,Active,119597822.0,1588.0,18.8336,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1558,743083,3,1,,144204963,14710,Active,119597822.0,1588.0,26.6032,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1559,743083,3,1,,144209709,14710,Active,119597822.0,1588.0,12.1352,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1560,743084,3,1,,144204674,14710,Inconclusive,,,26.6032,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1561,743084,3,1,,144204963,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1562,743084,3,1,,144209709,14710,Active,,,30.4821,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1563,743085,3,1,,144204674,14710,Active,51095037.0,196.0,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1564,743085,3,1,,144204963,14710,Active,51095037.0,196.0,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1565,743085,3,1,,144209709,14710,Active,51095037.0,196.0,12.1352,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1566,743086,3,1,,144204674,14710,Inconclusive,,,13.3332,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1567,743086,3,1,,144204963,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1568,743086,3,1,,144209709,14710,Active,,,12.1352,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1569,743091,2,1,,144204674,14710,Inconclusive,348019627.0,2099.0,26.6032,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1570,743091,2,1,,144204963,14710,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1571,743091,2,1,,144209709,14710,Inconclusive,348019627.0,2099.0,56.3264,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1572,743094,3,1,,144204674,14710,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1573,743094,3,1,,144204963,14710,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1574,743094,3,1,,144209709,14710,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1575,743122,2,1,,144204674,14710,Active,51095037.0,196.0,21.9584,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1576,743122,2,1,,144204963,14710,Active,51095037.0,196.0,29.8493,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1577,743122,2,1,,144209709,14710,Active,51095037.0,196.0,14.1486,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1578,743126,1,1,,92764758,14710,Inactive,119580345.0,50487.0,,,QFRET-based biochemical high throughput primary assay to identify inhibitors of human group III secreted phospholipase A2 enzyme (HGIII-sPLA2),Screening,,
1579,743139,2,1,,144204674,14710,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1580,743139,2,1,,144204963,14710,Active,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1581,743139,2,1,,144209709,14710,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1582,743140,2,1,,144204674,14710,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1583,743140,2,1,,144204963,14710,Inconclusive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1584,743140,2,1,,144209709,14710,Inconclusive,216409692.0,5468.0,40.239000000000004,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1585,743191,3,1,,144209709,14710,Active,216409692.0,5468.0,48.7506,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1586,743191,3,1,,170466062,14710,Active,216409692.0,5468.0,26.6011,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1587,743194,3,1,,144209709,14710,Inconclusive,,,24.4332,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
1588,743194,3,1,,170466062,14710,Inconclusive,,,9.4384,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
1589,743199,2,1,,144209709,14710,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1590,743199,2,1,,170466062,14710,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1591,743202,4,1,,144209709,14710,Inconclusive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1592,743202,4,1,,170466062,14710,Inconclusive,20149576.0,4780.0,1.3332,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1593,743203,3,1,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
1594,743203,3,1,,170466062,14710,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
1595,743209,3,1,,144209709,14710,Inconclusive,,,61.3734,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
1596,743209,3,1,,170466062,14710,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
1597,743210,4,1,,144209709,14710,Inconclusive,4504517.0,3315.0,43.449,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
1598,743210,4,1,,170466062,14710,Inconclusive,4504517.0,3315.0,6.6819,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
1599,743211,3,1,,144209709,14710,Active,,,24.4332,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1600,743211,3,1,,170466062,14710,Inconclusive,,,3.7575,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1601,743212,3,1,,144209709,14710,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1602,743212,3,1,,170466062,14710,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1603,743213,3,1,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1604,743213,3,1,,170466062,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1605,743215,3,1,,144209709,14710,Active,216409690.0,5467.0,24.4332,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1606,743215,3,1,,170466062,14710,Active,216409690.0,5467.0,23.7083,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1607,743217,3,1,,144209709,14710,Active,325495553.0,9971.0,7.7265,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1608,743217,3,1,,170466062,14710,Active,325495553.0,9971.0,5.3076,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1609,743218,3,1,,144209709,14710,Active,,,0.6137,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1610,743218,3,1,,170466062,14710,Inconclusive,,,2.113,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1611,743219,3,1,,144209709,14710,Inconclusive,20149576.0,4780.0,1.3103200000000002,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
1612,743219,3,1,,170466062,14710,Active,20149576.0,4780.0,1.9948,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
1613,743220,3,1,,144209709,14710,Inconclusive,325495553.0,9971.0,2.4433,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1614,743220,3,1,,170466062,14710,Inconclusive,325495553.0,9971.0,13.3322,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1615,743221,3,1,,144209709,14710,Inconclusive,,,8.6692,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1616,743221,3,1,,170466062,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1617,743222,3,1,,144209709,14710,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1618,743222,3,1,,170466062,14710,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1619,743223,3,1,,144209709,14710,Inconclusive,216409708.0,7421.0,19.408,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1620,743223,3,1,,170466062,14710,Active,216409708.0,7421.0,11.9856,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1621,743224,3,1,,144209709,14710,Active,,,21.7761,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1622,743224,3,1,,170466062,14710,Inconclusive,,,14.9589,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1623,743225,3,1,,144209709,14710,Inconclusive,,,2.1776,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1624,743225,3,1,,170466062,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1625,743226,2,1,,144209709,14710,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1626,743226,2,1,,170466062,14710,Active,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1627,743227,2,1,,144209709,14710,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1628,743227,2,1,,170466062,14710,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1629,743228,3,1,,144209709,14710,Inconclusive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
1630,743228,3,1,,170466062,14710,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
1631,743238,1,1,,92764758,14710,Inactive,,,,,High Content Cell-Based Imaging Primary HTS to Identify Small Molecules Involved in X-Chromosome Reactivation and Reprogramming Measured in Cell-Based System Using Imaging - 7015-01_Activator_SinglePoint_HTS_Activity_Set2,Screening,,
1632,743239,2,1,,144209709,14710,Inconclusive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1633,743239,2,1,,170466062,14710,Inconclusive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1634,743240,2,1,,144209709,14710,Inconclusive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1635,743240,2,1,,170466062,14710,Active,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1636,743241,2,1,,144209709,14710,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1637,743241,2,1,,170466062,14710,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1638,743242,2,1,,144209709,14710,Inconclusive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1639,743242,2,1,,170466062,14710,Active,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1640,743244,1,1,,144204674,14710,Active,,,1.4125,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
1641,743244,1,1,,144204963,14710,Active,,,6.3096,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
1642,743247,1,2,,92764758,14710,Inactive,,,,,Inhibition of Alexa 488-Fibronectin deposition #on AH1F cell monolayers Measured in Cell-Based System Using Plate Reader - 7059-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1643,743255,1,1,,92764758,14710,Inconclusive,118600387.0,7398.0,14.1254,Potency,Inhibitors of USP1/UAF1: Primary Screen,Confirmatory,,
1644,743263,1,1,,92764758,14710,Inactive,23510348.0,51567.0,,,Epi Absorbance-based biochemical high throughput confirmation assay to identify inhibitors of human tyrosyl-DNA phosphodiesterase 2 (TDP2),Screening,,
1645,743266,1,2,,92764758,14710,Inactive,296080761.0,5745.0,,Potency,qHTS of PTHR Inhibitors: Primary Screen,Confirmatory,,
1646,743267,1,1,,92764758,14710,Active,89348172.0,1080.0,7.74,AC50_uM,Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_Dose_CherryPick_Activity,Confirmatory,,
1647,743269,1,1,,92764758,14710,Active,2853980.0,,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
1648,743269,1,1,,92764758,14710,Active,6708281.0,11168.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
1649,743279,1,2,,92764758,14710,Active,10835145.0,3553.0,,,qHTS for Inhibitors of Inflammasome Signaling:  IL-1-beta AlphaLISA Primary Screen,Screening,,
1650,743287,1,1,,92764758,14710,Inactive,,,,,Luminescent GLuc Reporter Gene Assay Primary HTS to Identify Small Molecule Activator of Glucose Dependent Insulin Secretion Measured in Cell-Based System Using Plate Reader - 7055-01_Activator_SinglePoint_HTS_Activity,Screening,,
1651,743288,1,1,,17389015,14710,Inconclusive,,,39.8107,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
1652,743292,1,1,,17389015,14710,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
1653,743395,1,1,,92764758,14710,Active,,,21.53,AbsAC35_uM,HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Other_Dose_CherryPick_Activity_Set2,Confirmatory,,
1654,743397,1,1,,92764758,14710,Inactive,,,,,HTS for Inhibition of CaV1.3 ICDI/IQ interaction using a live-cell FRET assay Measured in Cell-Based System Using Plate Reader - 7081-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1655,743398,1,1,,92764758,14710,Inactive,,,,,Wnt/Beta-catenin HTS Measured in Cell-Based System Using Plate Reader - 2161-01_Activator_SinglePoint_HTS_Activity,Screening,,
1656,743402,1,1,,92764758,14710,Active,,,13.29,AbsAC35_uM,Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Fischer Rat Thyroid (FRT) Cells. Measured in Cell-Based System Using Plate Reader - 7017-02_Other_Dose_CherryPick_Activity,Confirmatory,,
1657,743445,1,1,,92764758,14710,Active,109633019.0,7468.0,,,"Development of Small Molecule Probes of the Histone Methyltransferase, NSD2 Measured in Biochemical System Using Plate Reader - 7053-01_Inhibitor_SinglePoint_HTS_Activity_Set2",Screening,,
1658,743748,1,1,,103207558,14710,Unspecified,,,,,Displacement of methyl green from DNA (unknown origin) after 24 hrs,Other,23474899.0,
1659,743749,1,1,,103207558,14710,Active,,,,,Binding affinity to DNA (unknown origin) at 5 mg/mL by RP-TLC plate analysis,Other,23474899.0,
1660,753092,4,1,,103207558,14710,Unspecified,,,,,Binding affinity to calf thymus DNA after 1.5 hrs by spectroscopic titration,Other,23644206.0,
1661,759750,1,1,,103207558,14710,Active,,,,,Binding affinity to DNA (unknown origin) assessed as induction of conformational changes at 300 uM after 2 hrs by CD spectrometric analysis,Other,23829449.0,
1662,762417,1,3,,103207558,14710,Unspecified,,,,,Antimicrobial activity against Mycobacterium smegmatis MC2 155 ATCC 700084 after 72 hrs by MTT assay,Other,23832254.0,
1663,771014,1,2,,103207558,14710,Active,,,,,Induction of DNA intercalation activity of calf thymus DNA topoisomerase 1 assessed as unwinding of pBR322 DNA at 2 ug/ml after 30 mins by Agarose gel electrophoresis,Other,23974019.0,
1664,774947,1,1,,103207558,14710,Active,,,,,Induction of Escherichia coli pBR322 DNA intercalating activity assessed as retardation of DNA at 1 to 2.5 uM after 20 mins by agarose gel electrophoresis,Other,24013413.0,
1665,977599,1,1,,103207558,14710,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
1666,977602,1,2,,103207558,14710,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
1667,1053131,3,1,,92764758,14710,Inactive,2853980.0,,,,Counterscreen for inhibitors of LEDGF/p75-dependent integration: TR-FRET-based biochemical high throughput counterscreen assay to identify activators of HIV-1 Integrase multimerization,Screening,,
1668,1053131,3,1,,92764758,14710,Inactive,6708281.0,11168.0,,,Counterscreen for inhibitors of LEDGF/p75-dependent integration: TR-FRET-based biochemical high throughput counterscreen assay to identify activators of HIV-1 Integrase multimerization,Screening,,
1669,1053135,2,1,,92764758,14710,Inactive,,,,,Counterscreen for inhibitors of LEDGF/p75-dependent integration: TR-FRET-based biochemical high throughput counterscreen assay to identify inhibitors that optically interfere with TR-FRET measurement,Screening,,
1670,1053136,1,1,,92764758,14710,Active,2853980.0,,,,Confirmation assay for inhibitors of LEDGF/p75-dependent integration: TR-FRET-based biochemical high throughput assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
1671,1053136,1,1,,92764758,14710,Active,6708281.0,11168.0,,,Confirmation assay for inhibitors of LEDGF/p75-dependent integration: TR-FRET-based biochemical high throughput assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
1672,1053173,1,1,,92764758,14710,Active,109633019.0,7468.0,0.293,AC50_uM,"Development of Small Molecule Probes of the Histone Methyltransferase, NSD2 Measured in Biochemical System Using Plate Reader - 7053-01_Inhibitor_Dose_CherryPick_Activity",Confirmatory,,
1673,1053174,1,1,,92764758,14710,Active,,,21.95,AbsAC35_uM,ALPHAscreen artifact counterscreen Measured in Biochemical System Using Plate Reader - 7053-03_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
1674,1053197,1,1,,92764758,14710,Active,74734243.0,54414.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of sialic acid acetylesterase (SIAE),Screening,,
1675,1060709,1,1,,103207558,14710,Unspecified,,,134.87,IC50,Cytotoxicity against mouse NIH/3T3 cells after 24 hrs by MTT assay,Confirmatory,24286761.0,
1676,1060710,3,1,,103207558,14710,Active,,,2.71,IC50,Inhibition of telomerase in human SW1116 cells after 24 hrs by TRAP-PCR-ELISA assay,Confirmatory,24286761.0,
1677,1067699,2,3,,103207558,14710,Active,6226780.0,7015.0,2.1,IC50,Inhibition of telomerase in human MGC803 cell extracts after 24 hrs by TRAP-PCR-ELISA,Confirmatory,24119869.0,
1678,1117263,1,1,,92764758,14710,Active,74734243.0,54414.0,,,Fluorescence polarization-based biochemical high throughput confirmation assay to identify inhibitors of sialic acid acetylesterase (SIAE),Screening,,
1679,1117298,1,2,,170466062,14710,Inactive,,,7.9433,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel",Confirmatory,,
1680,1117304,1,2,,170466062,14710,Active,,,28.1838,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel",Confirmatory,,
1681,1117305,1,2,,170466062,14710,Active,,,14.1254,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel",Confirmatory,,
1682,1117310,1,1,,170466062,14710,Inactive,,,7.943280000000001,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel",Confirmatory,,
1683,1117312,1,1,,170466062,14710,Active,,,14.1254,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel",Confirmatory,,
1684,1117314,1,1,,170466062,14710,Inactive,,,28.1838,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel",Confirmatory,,
1685,1117319,1,2,,92764758,14710,Inactive,9629361.0,155459.0,,Average IC50,High Throughput Screen to Identify Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G:#A time-resolved fluorescence resonance energy transfer (TR-FRET) assay for HIV-1 Vif-APOBEC3G interaction,Confirmatory,,
1686,1117319,1,2,,92764758,14710,Inactive,13399304.0,60489.0,,Average IC50,High Throughput Screen to Identify Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G:#A time-resolved fluorescence resonance energy transfer (TR-FRET) assay for HIV-1 Vif-APOBEC3G interaction,Confirmatory,,
1687,1117322,1,1,,170466062,14710,Active,,,3.3495,IC50,RKO viability from Cell TiterGlo-IC50,Confirmatory,,
1688,1117323,1,1,,170466062,14710,Inactive,,,20.0,IC50,SNU-C1 viability from Cell TiterGlo-IC50,Confirmatory,,
1689,1117326,1,1,,170466062,14710,Inactive,,,,,nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-screen,Screening,,
1690,1117329,1,1,,170466062,14710,Inactive,,,,,insulin secretion from INS-1E cells in the presence of 5 mM glucose-screen,Screening,,
1691,1117330,1,1,,170466062,14710,Inactive,,,20.0,IC50,HT-29 viability from Cell TiterGlo-IC50,Confirmatory,,
1692,1117332,1,1,,170466062,14710,Active,,,4.4376,IC50,HCT116 viability from Cell TiterGlo-IC50,Confirmatory,,
1693,1117334,1,1,,170466062,14710,Inactive,,,20.0,IC50,Colo320 viability from Cell TiterGlo-IC50,Confirmatory,,
1694,1117336,1,1,,170466062,14710,Active,,,,,GSK3B-pretreated HCT116 viability from Cell TiterGlo-screen,Screening,,
1695,1117338,1,1,,170466062,14710,Inactive,,,20.0,IC50,SW480 viability from Cell TiterGlo-IC50,Confirmatory,,
1696,1117340,1,1,,170466062,14710,Inactive,,,,,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-screen,Screening,,
1697,1117341,1,1,,170466062,14710,Inactive,,,,,GLP1 secretion from NCI-H716 cells-screen,Screening,,
1698,1117342,1,1,,170466062,14710,Active,,,,,HCT116 viability from Cell TiterGlo-screen,Screening,,
1699,1117343,1,1,,170466062,14710,Active,,,,,SW480 viability from Cell TiterGlo-screen,Screening,,
1700,1117346,1,1,,170466062,14710,Active,,,,,DLD-1 viability from Cell TiterGlo-screen,Screening,,
1701,1117347,1,1,,170466062,14710,Inactive,,,10.0,IC50,Decreased HeLa cell count-IC50,Confirmatory,,
1702,1117348,1,1,,170466062,14710,Inactive,,,10.0,IC50,Increased HeLa cells in S-phase-IC50,Confirmatory,,
1703,1117349,1,1,,170466062,14710,Inactive,,,10.0,IC50,Increased HeLa cells with 2N DNA content-IC50,Confirmatory,,
1704,1117350,1,1,,170466062,14710,Inactive,,,10.0,IC50,Increased chromatin condensation in HeLa cells-IC50,Confirmatory,,
1705,1117351,1,1,,170466062,14710,Inactive,,,10.0,IC50,Increased HeLa cells with 4N DNA content-IC50,Confirmatory,,
1706,1117352,1,1,,170466062,14710,Inactive,,,20.0,IC50,DLD-1 viability from Cell TiterGlo-IC50,Confirmatory,,
1707,1121883,1,2,,103207558,14710,Active,,,,,Binding affinity to Escherichia coli plasmid DNA assessed as intercalation at 1 ug/mL after 20 mins by agarose gel electrophoresis,Other,,
1708,1146806,1,1,,103207558,14710,Active,,,,,Induction of Escherichia coli omega enzyme-mediated relaxation of Escherichia coli (RR1) pBR313 closed circular DNA at 40 X 10'-12 mol preincubated for 10 mins followed by enzyme-addition measured after 30 mins by agarose gel electrophoretic analysis,Other,330857.0,
1709,1159509,1,1,,144209709,14710,Inconclusive,119626539.0,4790.0,27.4145,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
1710,1159509,1,1,,170466062,14710,Inconclusive,119626539.0,4790.0,9.5205,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
1711,1159515,1,1,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
1712,1159515,1,1,,170466062,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
1713,1159516,1,1,,144209709,14710,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
1714,1159516,1,1,,170466062,14710,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
1715,1159517,1,1,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
1716,1159517,1,1,,170466062,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
1717,1159518,1,1,,144209709,14710,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
1718,1159518,1,1,,170466062,14710,Inconclusive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
1719,1159519,1,1,,144209709,14710,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
1720,1159519,1,1,,170466062,14710,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
1721,1159520,1,1,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1722,1159520,1,1,,170466062,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1723,1159521,1,1,,144209709,14710,Inactive,15928672.0,19885.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
1724,1159521,1,1,,170466062,14710,Inactive,15928672.0,19885.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
1725,1159523,1,1,,144209709,14710,Inactive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
1726,1159523,1,1,,170466062,14710,Inactive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
1727,1159524,1,1,,92764758,14710,Inconclusive,,,22.3872,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
1728,1159524,1,1,,144204963,14710,Active,,,39.8107,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
1729,1159525,1,1,,144209709,14710,Inconclusive,,,27.4145,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
1730,1159525,1,1,,170466062,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
1731,1159526,1,1,,144209709,14710,Inconclusive,119627033.0,3725.0,21.7761,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
1732,1159526,1,1,,170466062,14710,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
1733,1159527,1,1,,144209709,14710,Inconclusive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
1734,1159527,1,1,,170466062,14710,Inconclusive,325495497.0,6256.0,2.1314,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
1735,1159528,1,1,,144209709,14710,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
1736,1159528,1,1,,170466062,14710,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
1737,1159529,1,1,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
1738,1159529,1,1,,170466062,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
1739,1159531,1,1,,144209709,14710,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
1740,1159531,1,1,,170466062,14710,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
1741,1159550,3,1,,252401681,14710,Inactive,12653201.0,5226.0,,,Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening,Screening,26479318.0,
1742,1159551,1,1,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
1743,1159551,1,1,,170466062,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
1744,1159552,1,1,,144209709,14710,Active,325495463.0,5914.0,24.2128,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1745,1159552,1,1,,170466062,14710,Active,325495463.0,5914.0,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1746,1159553,2,1,,144209709,14710,Inconclusive,325495463.0,5914.0,9.6393,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1747,1159553,2,1,,170466062,14710,Inconclusive,325495463.0,5914.0,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1748,1159555,1,1,,144209709,14710,Active,325495463.0,5914.0,26.1444,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
1749,1159555,1,1,,170466062,14710,Active,325495463.0,5914.0,26.6032,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
1750,1159606,1,1,,92764758,14710,Active,,,,,"uHTS identification of small molecule inhibitors of TWEAK-Fn14 interactions, using a cell-based reporter assay",Other,,
1751,1159614,1,2,,170466062,14710,Inactive,22328079.0,2581.0,,Potency,A Novel Cell-Based Assay to Identify Small Molecules for B -Galactocerebrosidase,Confirmatory,,
1752,1191411,1,2,,103207558,14710,Active,6226780.0,7015.0,2.1,IC50,Inhibition of telomerase in human MGC803 cells after 24 hrs by TRAP-PCR-ELISA,Confirmatory,25554922.0,
1753,1197382,1,2,,103207558,14710,Unspecified,,,,,Binding affinity to Escherichia coli pBR322 DNA assessed as DNA intercalation activity compound preincubated for 10 mins before enzyme addition by DNA unwinding assay in presence of topoisomerase 1,Other,25599951.0,
1754,1204358,1,2,,103207558,14710,Active,6226780.0,7015.0,2.33,IC50,Inhibition of telomerase in human MDA-MB-231 cells after 24 hrs by TRAP-PCR-ELISA,Confirmatory,25965778.0,
1755,1224834,3,1,,144209709,14710,Active,,,24.2128,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
1756,1224834,3,1,,170466062,14710,Active,,,6.6824,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
1757,1224835,1,1,,144209709,14710,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
1758,1224835,1,1,,170466062,14710,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
1759,1224836,1,1,,144209709,14710,Active,,,48.3109,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1760,1224836,1,1,,170466062,14710,Inconclusive,,,14.9601,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1761,1224837,1,1,,144209709,14710,Active,,,30.4821,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1762,1224837,1,1,,170466062,14710,Inconclusive,,,11.8832,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1763,1224838,1,1,,144209709,14710,Active,66775687.0,9970.0,21.5797,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1764,1224838,1,1,,170466062,14710,Active,66775687.0,9970.0,13.3332,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1765,1224839,1,1,,144209709,14710,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1766,1224839,1,1,,170466062,14710,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1767,1224840,3,1,,144209709,14710,Active,,,24.2128,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
1768,1224840,3,1,,170466062,14710,Inconclusive,,,9.4392,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
1769,1224841,3,1,,144209709,14710,Active,325495545.0,2101.0,7.6568,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1770,1224841,3,1,,170466062,14710,Active,325495545.0,2101.0,4.2163,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1771,1224842,3,1,,144209709,14710,Inactive,325495545.0,2101.0,4.8311,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1772,1224842,3,1,,170466062,14710,Inactive,325495545.0,2101.0,5.308,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1773,1224843,1,1,,144209709,14710,Inconclusive,119601739.0,7253.0,27.1672,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1774,1224843,1,1,,170466062,14710,Inconclusive,119601739.0,7253.0,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1775,1224844,1,1,,144209709,14710,Active,,,21.7761,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
1776,1224844,1,1,,170466062,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
1777,1224845,1,1,,144209709,14710,Inconclusive,344243002.0,100757539.0,100.286,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
1778,1224845,1,1,,170466062,14710,Inconclusive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
1779,1224846,1,1,,144209709,14710,Inconclusive,11995455.0,3091.0,21.7761,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
1780,1224846,1,1,,170466062,14710,Inconclusive,11995455.0,3091.0,7.5624,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
1781,1224847,1,1,,144209709,14710,Inconclusive,,,56.3948,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
1782,1224847,1,1,,170466062,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
1783,1224848,3,1,,144209709,14710,Active,325495545.0,2101.0,5.4206,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1784,1224848,3,1,,170466062,14710,Active,325495545.0,2101.0,5.308,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1785,1224849,3,1,,144209709,14710,Inactive,325495545.0,2101.0,5.4206,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1786,1224849,3,1,,170466062,14710,Inactive,325495545.0,2101.0,5.308,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1787,1224852,2,1,,170466062,14710,Inactive,,,6.9015,Potency,Cell viability assay for measurement of the protective activity of small molecules against cell death caused by Zika virus infection in human neural progenitor cells (hNPCs),Confirmatory,,
1788,1224853,2,1,,170466062,14710,Inconclusive,,,3.8810000000000002,Potency,Confirmation assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
1789,1224854,2,1,,170466062,14710,Inconclusive,,,1.3769999999999998,Potency,Cell viability assay for measurement of the protective activity of small molecules against cell death caused by Zika virus infection in human astrocytoma cells,Confirmatory,,
1790,1224855,2,1,,170466062,14710,Inactive,,,,Potency,Confirmation assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1791,1224856,2,1,,170466062,14710,Active,,,1.9451,Potency,Cell viability assay for measurement of the protective activity of small molecules against cell death caused by Zika virus infection in human astrocytes,Confirmatory,,
1792,1224857,2,1,,170466062,14710,Inconclusive,,,3.5481,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1793,1224858,2,1,,170466062,14710,Inconclusive,,,6.151,Potency,Confirmation assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytes,Confirmatory,,
1794,1224859,2,1,,170466062,14710,Inconclusive,,,7.0795,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
1795,1224860,2,1,,170466062,14710,Inconclusive,,,27.4753,Potency,Compound cytotoxicity measured by an ATP content assay as a counter-screen for lead compounds in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1796,1224861,2,1,,170466062,14710,Inactive,,,,Potency,Compound cytotoxicity measured by an ATP content assay as a counter-screen for lead compounds in human astrocytes,Confirmatory,,
1797,1224862,2,1,,170466062,14710,Inactive,,,,Potency,Compound cytotoxicity measured by an ATP content assay as a counter-screen for lead compounds in human astrocytoma cell line (SNB-19),Confirmatory,,
1798,1224865,1,2,,92764758,14710,Inactive,578162.0,,,,Identify inhibitors of HNF4 alpha protein binding to DNA,Screening,,
1799,1224867,1,1,,144209709,14710,Inconclusive,,,38.724000000000004,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
1800,1224867,1,1,,170466062,14710,Inconclusive,,,23.9145,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
1801,1224868,1,1,,144209709,14710,Active,,,4.3449,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
1802,1224868,1,1,,170466062,14710,Active,,,5.3538,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
1803,1224869,1,1,,144209709,14710,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
1804,1224869,1,1,,170466062,14710,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
1805,1224870,1,1,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
1806,1224870,1,1,,170466062,14710,Inconclusive,,,26.8325,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
1807,1224871,1,1,,144209709,14710,Inactive,,,1.374,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
1808,1224871,1,1,,170466062,14710,Inactive,,,3.0107,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
1809,1224872,1,1,,144209709,14710,Active,,,17.2974,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
1810,1224872,1,1,,170466062,14710,Active,,,23.9145,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
1811,1224873,1,1,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
1812,1224873,1,1,,170466062,14710,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
1813,1224874,1,1,,144209709,14710,Active,,,3.4513,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
1814,1224874,1,1,,170466062,14710,Active,,,2.1314,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
1815,1224875,1,1,,144209709,14710,Inactive,,,1.374,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
1816,1224875,1,1,,170466062,14710,Inactive,,,2.6832,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
1817,1224876,1,1,,144209709,14710,Inactive,,,10.9139,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
1818,1224876,1,1,,170466062,14710,Inactive,,,1.8996,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
1819,1224877,1,1,,144209709,14710,Inconclusive,,,34.5128,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
1820,1224877,1,1,,170466062,14710,Inconclusive,,,26.8325,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
1821,1224878,1,1,,144209709,14710,Inactive,,,10.9139,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
1822,1224878,1,1,,170466062,14710,Inactive,,,1.5089,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
1823,1224879,1,1,,144209709,14710,Inactive,,,10.9139,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
1824,1224879,1,1,,170466062,14710,Inactive,,,1.5089,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
1825,1224880,1,1,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
1826,1224880,1,1,,170466062,14710,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
1827,1224881,1,1,,144209709,14710,Inactive,,,1.374,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
1828,1224881,1,1,,170466062,14710,Inactive,,,2.6832,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
1829,1224882,1,1,,144209709,14710,Inactive,,,10.9139,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
1830,1224882,1,1,,170466062,14710,Inactive,,,1.3448,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
1831,1224883,1,1,,144209709,14710,Inactive,,,9.727,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
1832,1224883,1,1,,170466062,14710,Inactive,,,1.693,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
1833,1224884,1,1,,144209709,14710,Inactive,,,1.2246,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1834,1224884,1,1,,170466062,14710,Inactive,,,2.6832,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1835,1224885,1,1,,144209709,14710,Inconclusive,,,21.7761,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1836,1224885,1,1,,170466062,14710,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1837,1224886,1,1,,144209709,14710,Active,,,6.8862,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1838,1224886,1,1,,170466062,14710,Active,,,9.5205,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1839,1224887,1,1,,144209709,14710,Active,,,34.5128,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1840,1224887,1,1,,170466062,14710,Inconclusive,,,26.8325,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1841,1224888,1,1,,144209709,14710,Inactive,,,1.374,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1842,1224888,1,1,,170466062,14710,Inactive,,,2.6832,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1843,1224889,1,1,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1844,1224889,1,1,,170466062,14710,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1845,1224890,1,1,,144209709,14710,Inactive,,,10.9139,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1846,1224890,1,1,,170466062,14710,Inactive,,,1.5089,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1847,1224892,1,1,,144209709,14710,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1848,1224892,1,1,,170466062,14710,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1849,1224893,1,1,,144209709,14710,Inconclusive,66775687.0,9970.0,20.7672,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1850,1224893,1,1,,170466062,14710,Inconclusive,66775687.0,9970.0,16.1535,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1851,1224894,1,1,,144209709,14710,Inconclusive,11995455.0,3091.0,48.7506,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
1852,1224894,1,1,,170466062,14710,Inconclusive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
1853,1224895,1,1,,144209709,14710,Inconclusive,119601739.0,7253.0,25.6475,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1854,1224895,1,1,,170466062,14710,Inconclusive,119601739.0,7253.0,35.476,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1855,1224896,1,1,,144209709,14710,Inconclusive,344243002.0,100757539.0,59.7364,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
1856,1224896,1,1,,170466062,14710,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
1857,1259241,1,1,,144209709,14710,Active,,,30.4821,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
1858,1259241,1,1,,170466062,14710,Inconclusive,,,23.7101,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
1859,1259242,1,1,,144209709,14710,Active,,,24.2128,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
1860,1259242,1,1,,170466062,14710,Active,,,13.3332,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
1861,1259243,1,1,,144209709,14710,Active,124375976.0,367.0,15.2773,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
1862,1259243,1,1,,170466062,14710,Active,124375976.0,367.0,16.7855,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
1863,1259244,1,1,,144209709,14710,Active,348019627.0,2099.0,27.1672,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
1864,1259244,1,1,,170466062,14710,Active,348019627.0,2099.0,21.1317,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
1865,1259247,1,1,,144209709,14710,Inconclusive,124375976.0,367.0,19.2329,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
1866,1259247,1,1,,170466062,14710,Inconclusive,124375976.0,367.0,18.8336,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
1867,1259248,1,1,,144209709,14710,Inconclusive,348019627.0,2099.0,28.2301,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
1868,1259248,1,1,,170466062,14710,Inconclusive,348019627.0,2099.0,16.1535,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
1869,1259310,1,1,,321946854,14710,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1870,1259313,1,1,,92764758,14710,Inactive,,,,,uHTS identification of small molecule modulators of NR3A,Screening,,
1871,1259318,1,1,,92764758,14710,Inactive,,,,,uHTS identification of small molecule modulators of Rev-erb Alpha.,Screening,,
1872,1259344,1,1,,144204674,14710,Inconclusive,,,14.1254,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
1873,1259344,1,1,,144204963,14710,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
1874,1259355,1,1,,144204674,14710,Active,,,7.9433,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-1,Confirmatory,,
1875,1259355,1,1,,144204963,14710,Inconclusive,,,11.2202,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-1,Confirmatory,,
1876,1259356,1,1,,144204674,14710,Inconclusive,,,7.3048,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-2,Confirmatory,,
1877,1259356,1,1,,144204963,14710,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-2,Confirmatory,,
1878,1259364,1,1,,144209709,14710,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
1879,1259364,1,1,,170466062,14710,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
1880,1259365,1,1,,144209709,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
1881,1259365,1,1,,170466062,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
1882,1259366,1,1,,144209709,14710,Active,,,54.2058,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1883,1259366,1,1,,170466062,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1884,1259367,1,1,,144209709,14710,Active,,,48.3109,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1885,1259367,1,1,,170466062,14710,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1886,1259368,1,1,,144209709,14710,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1887,1259368,1,1,,170466062,14710,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1888,1259369,1,1,,144209709,14710,Active,109731339.0,2737.0,17.1414,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1889,1259369,1,1,,170466062,14710,Inconclusive,109731339.0,2737.0,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1890,1259377,1,1,,144209709,14710,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1891,1259377,1,1,,170466062,14710,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1892,1259378,1,1,,144209709,14710,Active,54288833.0,2100.0,17.1414,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1893,1259378,1,1,,170466062,14710,Active,54288833.0,2100.0,2.6603,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1894,1259379,1,1,,144209709,14710,Active,,,24.2128,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1895,1259379,1,1,,170466062,14710,Active,,,10.5909,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1896,1259380,1,1,,144209709,14710,Active,,,1.5277,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1897,1259380,1,1,,170466062,14710,Active,,,1.0591,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1898,1259381,1,1,,144209709,14710,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
1899,1259381,1,1,,170466062,14710,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
1900,1259382,1,1,,144209709,14710,Inconclusive,,,1.3616,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1901,1259382,1,1,,170466062,14710,Inconclusive,,,1.3333,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1902,1259383,1,1,,144209709,14710,Inactive,348019627.0,2099.0,68.241,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
1903,1259383,1,1,,170466062,14710,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
1904,1259384,1,1,,144209709,14710,Inconclusive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
1905,1259384,1,1,,170466062,14710,Inconclusive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
1906,1259385,1,1,,144209709,14710,Inconclusive,119601739.0,7253.0,27.1672,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1907,1259385,1,1,,170466062,14710,Inconclusive,119601739.0,7253.0,23.7101,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1908,1259386,1,1,,144209709,14710,Active,,,48.3109,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1909,1259386,1,1,,170466062,14710,Active,,,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1910,1259387,1,1,,144209709,14710,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
1911,1259387,1,1,,170466062,14710,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
1912,1259388,1,1,,144209709,14710,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
1913,1259388,1,1,,170466062,14710,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
1914,1259389,1,1,,124637205,14710,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
1915,1259390,1,1,,144209709,14710,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1916,1259390,1,1,,170466062,14710,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1917,1259391,1,1,,144209709,14710,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
1918,1259391,1,1,,170466062,14710,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
1919,1259392,1,1,,144209709,14710,Inconclusive,109731339.0,2737.0,19.9854,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1920,1259392,1,1,,170466062,14710,Inconclusive,109731339.0,2737.0,23.7101,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1921,1259393,1,1,,144209709,14710,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
1922,1259393,1,1,,170466062,14710,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
1923,1259394,1,1,,144209709,14710,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1924,1259394,1,1,,170466062,14710,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1925,1259395,1,1,,144209709,14710,Inconclusive,119601739.0,7253.0,54.2058,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1926,1259395,1,1,,170466062,14710,Inconclusive,119601739.0,7253.0,28.1796,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1927,1259396,1,1,,144209709,14710,Inconclusive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1928,1259396,1,1,,170466062,14710,Inconclusive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1929,1259400,1,1,,92764758,14710,Active,166209887.0,59350.0,,,qHTS Assay for Antagonists of the Relaxin Receptor RXFP1,Screening,,
1930,1259400,1,1,,170466062,14710,Inconclusive,166209887.0,59350.0,,,qHTS Assay for Antagonists of the Relaxin Receptor RXFP1,Screening,,
1931,1259401,1,1,,144209709,14710,Inconclusive,325495545.0,2101.0,7.091080000000001,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1932,1259401,1,1,,170466062,14710,Active,325495545.0,2101.0,3.4801699999999998,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1933,1259402,1,1,,144209709,14710,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1934,1259402,1,1,,170466062,14710,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1935,1259403,1,1,,144209709,14710,Active,325495545.0,2101.0,5.63264,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1936,1259403,1,1,,170466062,14710,Inconclusive,325495545.0,2101.0,4.91587,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1937,1259404,1,1,,144209709,14710,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1938,1259404,1,1,,170466062,14710,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1939,1259407,1,1,,363898967,14710,Inactive,,,,,CCRIS mutagenicity studies,Other,,
1940,1259408,1,1,,363896011,14710,Active,,,,,GENE-TOX mutagenicity studies,Other,,
1941,1259415,1,1,,92764758,14710,Active,,,,,qHTS Assay for inhibitors of the human cytomegalovirus (HCMV),Screening,,
